A61K

Drug Preparations & Formulations

EPO Patent Bulletin

← All categories
Filter: All Amended Grant Correction Grant Limitation Publication Search Report

740 items

Publication

Ras Inhibitors, Compositions And Methods Of Use Thereof

EP4416131A1 · Genetolead Inc. · Mar 18, 2026
Publication

Protection Of Next Generation Probiotics During Processing

EP4412597A1 · Massachusetts Institute of Technology · Mar 18, 2026
Publication

Recombinant Newcastle Disease Virus Expressing Spike Protein Of Sars Cov 2 Delta Variant And Uses Thereof

EP4408463A2 · Icahn School of Medicine at Mount Sinai · Mar 18, 2026
Publication

Peptide Having Anti Aging Activity, And Use Thereof

EP4410817A1 · Caregen Co., Ltd. · Mar 18, 2026
Publication

Bcl Xl Degraders And Uses Thereof

EP4401729A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Multiplex Base Editing In Hematopoietic Cells

EP4401744A1 · Vor Biopharma Inc. · Mar 18, 2026
Publication

Novel Protein And Pharmaceutical Composition Comprising Same For Prevention Or Treatment Of Cancer

EP4403567A1 · Cellemedy Co., Ltd · Mar 18, 2026
Publication

Heteronucleic Acid Including 2' Modified Nucleoside

EP4403191A1 · National University Corporation Tokyo Medical and Dental University · Mar 18, 2026
Publication

Inhaler

EP4398964A1 · Niconox LLC · Mar 18, 2026
Publication

Composition Comprising A Polar Phase And A Non Polar Phase

EP4209207A1 · PM-International AG · Mar 18, 2026
Publication

Compositions For Use In Treatment Of Type Vii Collagen Deficiencies

EP4245314A2 · Innovator 21, LLC · Mar 18, 2026
Publication

Octahydro Fused Azadecalin Glucocorticoid Receptor Modulators

EP4219494A1 · Corcept Therapeutics Incorporated · Mar 18, 2026
Publication

Bisphosphocin Gel Formulations And Uses Thereof

EP4241769A2 · Lakewood Amedex, Inc. · Mar 18, 2026
Publication

Use Of Anti Il 1 Beta Antibodies

EP4218815A2 · Novartis AG · Mar 18, 2026
Publication

Antagonists Of Cav 2.3

EP4436664A1 · Lario Therapeutics Limited · Mar 18, 2026
Publication

Novel Ionizable Lipids And Lipid Nanoparticles And Methods Of Using The Same

EP4433450A1 · Sail Biomedicines, Inc. · Mar 18, 2026
Publication

Systems And Methods For Regulating Aberrant Gene Expressions

EP4355357A1 · Epicrispr Biotechnologies, Inc. · Mar 18, 2026
Publication

Methods And Compositions For Treating Cancer

EP4355311A1 · Onconova Therapeutics, Inc. · Mar 18, 2026
Publication

Dimeric Collagen Hybridizing Peptides And Methods Of Use Thereof

EP4355769A1 · University of Utah Research Foundation · Mar 18, 2026
Publication

Topical Probiotic Delivery System

EP4355296A1 · Jeen International Corp. · Mar 18, 2026
Publication

Orally Bioavailable Nucleoside Analogs

EP4355755A1 · Venatorx Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Diffractive Effect Pigments Having A Reflective Core And Semiconductor Coatings

EP4453099A1 · ECKART America Corporation · Mar 18, 2026
Publication

Inhibitory Peptides For The Diagnostic And/Or Treatment Of Tauopathies

EP4441082A1 · Université de Rennes · Mar 18, 2026
Publication

Deuterated (Trifluoromethyl)pyrimidine 2 Amine Compounds As Potentiators Of The Hmrgx1 Receptor

EP4429764A1 · ELI LILLY AND COMPANY · Mar 18, 2026
Publication

Development Of A New Family Of Nanocarriers Derived From Natural Tetrameric Acid Lipids

EP4433449A1 · Université de Rennes · Mar 18, 2026
Publication

Safe Administration Of Mmp 12 Inhibitor

EP4351566A1 · Foresee Pharmaceuticals USA, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Neurofibromatic Disorders

EP4352079A1 · NF2 Therapeutics, Inc. · Mar 18, 2026
Publication

Antibacterial Composition Production Method, Antibacterial Composition, Antibacterial Method, Antibacterial Agent, Cosmetic, And Dermatological Topical Agent

EP4353081A1 · Ushio Denki Kabushiki Kaisha · Mar 18, 2026
Publication

Compositions And Methods For Treating Interleukin 7 Receptor Deficiency

EP4426726A1 · The Children's Hospital Of Philadelphia · Mar 18, 2026
Publication

Methods Of Treating Cancer

EP4426360A1 · Fusion Pharmaceuticals Inc. · Mar 18, 2026
Publication

Betacoronavirus Attenuated Strain

EP4431599A1 · The Research Foundation for Microbial Diseases of Osaka University · Mar 18, 2026
Publication

Adhesive Patch With Cover Material

EP4410282A1 · Hisamitsu Pharmaceutical Co., Inc. · Mar 18, 2026
Publication

Novel Crystal Forms Of Peptide Boric Acid Compound And Preparation Methods Therefor

EP4431515A1 · Jiangsu Chuangte Pharmaceutical Technology Co., Ltd. · Mar 18, 2026
Publication

Bcma Monoclonal Antibody And The Antibody Drug Conjugate

EP4426741A1 · Hangzhou DAC Biotech Co., Ltd. · Mar 18, 2026
Publication

Compositions For Treatment Of Hair Loss

EP4346801A1 · INNOCAN PHARMA LTD. · Mar 18, 2026
Publication

Lpa Receptor Antagonists And Uses Thereof

EP4444707A1 · GILEAD SCIENCES, INC. · Mar 18, 2026
Publication

Cancer Treatment Combinations

EP4373525A1 · Viracta Subsidiary, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Opioid Dependence And Withdrawal

EP4373484A1 · CASE WESTERN RESERVE UNIVERSITY · Mar 18, 2026
Publication

Vedolizumab Formulation

EP4456917A1 · Polpharma Biologics S.A. · Mar 18, 2026
Publication

A Substituted Aromatic Dicarbonic Acid Amide As An Inhibitor Of The Ferroptosis Suppressor Protein 1 (Fsp1)

EP4456888A1 · Julius-Maximilians-Universität Würzburg · Mar 18, 2026
Publication

Methods Of Treating Alzheimer's Disease

EP4370131A1 · Athira Pharma, Inc. · Mar 18, 2026
Publication

Cyclopentathiophene Carboxamide Derivatives As Platelet Activating Factor Receptor Antagonists

EP4452985A1 · BOEHRINGER INGELHEIM INTERNATIONAL GMBH · Mar 18, 2026
Publication

Injectable And Inhalable Formulations Containing Optionally Deuterated Dimethyltryptamine

EP4433049A1 · Cybin UK Ltd · Mar 18, 2026
Publication

Ketamine And Cannabis For The Treatment Of Emotional Disorders

EP4329737A1 · Progressive Therapeutics, Inc. · Mar 18, 2026
Publication

Personalized Immunotherapy Using Intestinal Metabolites

EP4329787A1 · Infinant Health, Inc · Mar 18, 2026
Publication

Purification Of Burkholderia Capsular Polysaccharides

EP4330292A1 · Board of Regents of the Nevada System of Higher Education, on Behalf of the University of Nevada, Reno · Mar 18, 2026
Publication

Substituted 2 (2,6 Dioxopiperidin 3 Yl) 5 (1 Piperidin 4 Yl)isoindoline 1,3 Dione Derivatives And Uses Thereof

EP4329744A1 · Neomorph, Inc. · Mar 18, 2026
Publication

Antibodies For The Treatment And Prevention Of Covid 19 And Emerging Variants

EP4330279A2 · The Trustees of Columbia University in the City of New York · Mar 18, 2026
Publication

Novel Anti Cd5 Chimeric Antigen Receptor And Immune Cell Expressing Same

EP4332118A1 · Korea Research Institute of Bioscience and Biotechnology · Mar 18, 2026
Publication

Coronavirus Vaccines And Methods Of Use

EP4404960A1 · BioNTech SE · Mar 18, 2026
Publication

Methods For Treatment Of Cancers

EP4326344A1 · Fusion Pharmaceuticals Inc. · Mar 18, 2026
Publication

Adjuvanted Vaccine Composition And Methods

EP4326320A1 · D4 LABS, LLC · Mar 18, 2026
Publication

Engineering B Cell Based Protein Factories To Treat Serious Diseases

EP4326290A2 · Walking Fish Therapeutics, Inc. · Mar 18, 2026
Publication

Bifunctional Molecules For Selective Modification Of Target Substrates

EP4320126A2 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Coadministration Of Mirodenafil With Cort 108297 For Preventing And Treating Dementia

EP4327813A1 · ARIBIO CO., LTD. · Mar 18, 2026
Publication

Anti Inflammatory Siglec Proteins And Methods Of Making And Using Same

EP4323378A2 · Palleon Pharmaceuticals Inc. · Mar 18, 2026
Publication

Dna Binding Proteins For Regulating Gene Expression

EP4323515A1 · Altius Institute For Biomedical Sciences · Mar 18, 2026
Publication

Synthetic Rocaglates With Broad Spectrum Antiviral Activities And Uses Thereof

EP4322940A1 · Memorial Sloan-Kettering Cancer Center · Mar 18, 2026
Publication

Novel Compositions Enriched In Gamma Delta T Cells, Methods Of Preparation, And Uses Thereof

EP4322972A1 · Acepodia Biotechnologies Ltd. · Mar 18, 2026
Publication

Probiotic Composition For Weaning Infants

EP4322771A1 · Infinant Health, Inc · Mar 18, 2026
Publication

Cell Penetrating Peptide, Anti Cancer Peptide, And Pharmaceutical Composition For Preventing Or Treating Cancer, Comprising Same

EP4324841A1 · Onecuregen Co., Ltd. · Mar 18, 2026
Publication

Polynucleotides Capable Of Enhanced Protein Expression And Uses Thereof

EP4323382A1 · Biorchestra Co., Ltd. · Mar 18, 2026
Publication

Compositions Having High Levels Of Dpa (N 3) And Methods For Producing

EP4436398A1 · DSM IP Assets B.V. · Mar 18, 2026
Publication

4 Ethynyl 3 Hydroxy Tetrahydrofuranyl Adenine Phosphoramidates And Related Compounds And Their Use In Treating Medical Conditions

EP4358968A1 · Rome Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Pulmonary Hypertension

EP4358991A1 · Acceleron Pharma, Inc. · Mar 18, 2026
Publication

Methods For Delivering Agents With Pre Filled Syringes To Minimize Intraocular Inflammation

EP4398927A1 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Antiviral Structurally Stapled Sars Cov 2 Peptide Cholesterol Conjugates And Uses Thereof

EP4399220A1 · Dana-Farber Cancer Institute, Inc. · Mar 18, 2026
Publication

Dosing Of Bispecific T Cell Engager

EP4319815A1 · Anji Bruno, LLC · Mar 18, 2026
Publication

Use Of Sos1 Inhibitors With Ras Inhibitors To Treat Cancers

EP4319745A1 · Revolution Medicines, Inc. · Mar 18, 2026
Publication

Bispecific Molecules And Related Compositions And Methods

EP4314050A1 · The Board of Trustees of the Leland Stanford Junior University · Mar 18, 2026
Publication

Staphylococcus Aureus Vaccine Compositions

EP4313303A1 · Janssen Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Pyrimidine Derivative Having Protein Kinase Inhibitory Activity, And Therapeutic Pharmaceutical Composition Comprising Same

EP4286376A1 · Therapex Co., Ltd. · Mar 18, 2026
Publication

Heteroaryl Derivatives As Pd1/Pd L1 Inhibitors For The Treatment Of Hbv And Cancer

EP4313968A2 · Arbutus Biopharma Corporation · Mar 18, 2026
Publication

Biomarkers For Sting Agonists And Methods Of Using The Same

EP4398901A1 · Eisai R&D Management Co., Ltd. · Mar 18, 2026
Publication

Compositions Comprising Fluid Gels For Tissue Separation

EP4313171A1 · Aleo BME, Inc. · Mar 18, 2026
Publication

Compounds For Regulating Trained Immunity, And Their Methods Of Use

EP4308105A1 · Trained Therapeutix Discovery, Inc. · Mar 18, 2026
Publication

T Cell Modulatory Polypeptides And Methods Of Use Thereof

EP4308143A1 · Cue Biopharma, Inc. · Mar 18, 2026
Publication

Compounds For The Treatment Of Disorders And Salts And Polymorphs Thereof

EP4308541A1 · OccuRx Pty Ltd · Mar 18, 2026
Publication

A Pharmaceutically Acceptable Aqueous Gel Composition For Mrna Delivery

EP4346914A1 · Magle Chemoswed AB · Mar 18, 2026
Publication

Reconstitution And Uses Of Flavivirus Epitopes

EP4347622A1 · Ramot at Tel-Aviv University Ltd. · Mar 18, 2026
Publication

Phosphate Of Trifluoromethyl Substituted Sulfonamide Compound

EP4353722A1 · CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. · Mar 18, 2026
Publication

Skin Care Composition

EP4433019A1 · Unilever IP Holdings B.V. · Mar 18, 2026
Publication

Nitroxoline For Use In The Treatment Or Prevention Of A Plexiform Neurofibroma

EP4433054A1 · Healx Limited · Mar 18, 2026
Publication

Cell Therapies For The Treatment Of Small Volume Stroke

EP4346853A1 · SanBio, Inc. · Mar 18, 2026
Publication

Extraction And Purification Of The Distillation Residues Of Black Spruce And Labrador's Tea And Combination Thereof

EP4351608A1 · Silicycle Inc. · Mar 18, 2026
Publication

Pharmaceutical Composition And Kit Comprising An Immunomodulatory Substance For Treating Diseases

EP4422671A1 · ellennbe GmbH · Mar 18, 2026
Publication

Medical Device Comprising A Skin Conditioning Unit And An Applicator Unit

EP4422669A1 · ellennbe GmbH · Mar 18, 2026
Publication

Tyk2 Degraders And Uses Thereof

EP4423086A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Engineered Antimicrobial Peptides And Usage Thereof

EP4337321A2 · University of Pittsburgh - of the Commonwealth System of Higher Education · Mar 18, 2026
Publication

Immunosuppressive Antigen Specific Chimeric Antigen Receptor Treg Cells For Prevention And/Or Treatment Of Autoimmune And Alloimmune Disorders

EP4340895A1 · The University of Toledo · Mar 18, 2026
Publication

Immunomodulation Of Tumor Microenvironment

EP4340682A1 · Genkin, Dmitry Dmitrievich · Mar 18, 2026
Publication

Polyclonal Antibodies To Treat Respiratory Syncytial Virus

EP4351646A1 · Lactiga, Inc. · Mar 18, 2026
Publication

Mrna Vaccine Composition

EP4419081A1 · Sail Biomedicines, Inc. · Mar 18, 2026
Publication

Indications For Anti Prame Binders

EP4412642A2 · immatics biotechnologies GmbH · Mar 18, 2026
Publication

Direct Granules With A Combination Of Retarded And Fast Releasing Magnesium

EP4228609A1 · HERMES PHARMA GmbH · Mar 18, 2026
Publication

Gene Editing Tools

EP4401757A1 · Life Technologies Corporation · Mar 18, 2026
Publication

Composition For Reducing The Concentration Of Viruses And Of African Swine Fever Virus (Asfv) In Animal Feed And Litter Materials For Stables

EP4412470A1 · Dr. Eckel Vermögensverwaltung GmbH · Mar 18, 2026
Publication

Peptide Fc Fusions For Treating Amyloid Disorders

EP4333871A1 · University of Tennessee Research Foundation · Mar 18, 2026
Publication

Cdk2 Degraders And Uses Thereof

EP4334307A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Topical Compositions Of 2 Phenyl 3,4 Dihydropyrrolo[2,L F] [1,2,4]Triazinone Derivatives And Uses Thereof

EP4408391A1 · Topadur Pharma AG · Mar 18, 2026
Publication

Mesenchymal Stem Cells For Use In Treating Diabetes Caused By Immune Checkpoint Inhibitors

EP4134088A1 · Rohto Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Ibudilast For Preventing Eye Cancer Metastasis

EP4376838A1 · MediciNova, Inc. · Mar 18, 2026
Publication

Irak4 Degraders And Uses Thereof

EP4291197A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak4 Degraders And Uses Thereof

EP4291187A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Recombinant Human Acid Alpha Glucosidase And Uses Thereof

EP4291225A1 · Amicus Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Improving Relaxation, Sleep, Cognition, And/Or Physical Performance

EP4288039A1 · Health Via Modern Nutrition Inc. · Mar 18, 2026
Publication

Methods For Treating Autism Spectrum Disorder

EP4288150A1 · The General Hospital Corporation · Mar 18, 2026
Publication

Preventive Or Therapeutic Agent For Inflammatory Disorders And/Or Pain Disorders

EP4272759A1 · Kyowa Pharma Chemical Co., Ltd. · Mar 18, 2026
Publication

Novel Boron Carrier, Preparation Method And Pharmaceutical Formulation Thereof

EP4324836A1 · Peking University · Mar 18, 2026
Publication

Drug Conjugate Of Glucocorticoid Receptor Agonist, And Application Thereof In Medicine

EP4289857A1 · Shanghai Senhui Medicine Co., Ltd. · Mar 18, 2026
Publication

Crystal Form Of 3 Hydroxy 5 Pregnane 20 One Derivative, And Preparation Method Therefor And Use Thereof

EP4289856A1 · TWi Biotechnology, Inc. · Mar 18, 2026
Publication

Chimeric Antigen Receptor With Endogenous Protein Molecule Replacing Single Domain Antibody

EP4289867A1 · Zhejiang University · Mar 18, 2026
Publication

Nucleotide Mixture For Use In Treating Allergic Rhinitis

EP4108245A1 · Chen, Yusong · Mar 18, 2026
Publication

Methods And Compositions For Tau Reduction Gene Therapy

EP4362986A1 · THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM · Mar 18, 2026
Publication

Epigenetic Gene Regulation To Treat Neurological Diseases And Pain

EP4284927A2 · Navega Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions Comprising Hiv Envelopes To Induce Hiv 1 Antibodies

EP4284427A1 · Duke University · Mar 18, 2026
Publication

Platelet Alpha Granules For Delivery Of Multiple Proteins

EP4284917A2 · Longitude Therapeutics S.r.l. · Mar 18, 2026
Publication

Immunosuppressive Pharmaceutical Composition Including Benzene Derivative As Immunosuppressant

EP4271369A1 · Provibio Co., Ltd. · Mar 18, 2026
Publication

Pharmaceutical Composition For Treating Liver Diseases Using Ssu72

EP4247415A1 · Curogen Technology Co., Ltd. · Mar 18, 2026
Publication

Phenol Derivative And Application Thereof In Medicaments

EP4286359A1 · Hinye Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Antibody Drug Conjugate, Preparation Method Therefor And Application Thereof

EP4331616A1 · Tsinghua University · Mar 18, 2026
Publication

Alkyl Carboxylic Acid Compounds And Application Thereof

EP4339184A1 · Medshine Discovery Inc. · Mar 18, 2026
Publication

1 Methylxanthine Based Bioactive Composition And Method Of Use Thereof

EP4319759A1 · Ingenious Ingredients, LP · Mar 18, 2026
Publication

Salmonella Vaccine

EP4319558A1 · University of Maryland, College Park · Mar 18, 2026
Publication

Cationic Lipid, Liposome Containing Cationic Lipid, And Nucleic Acid Pharmaceutical Composition Containing Liposome And Preparation And Application Thereof

EP4276090A1 · Xiamen Sinopeg Biotech Co., Ltd. · Mar 18, 2026
Publication

Assay Method For Relaxin

EP4402474A1 · Bellylabs OY · Mar 18, 2026
Publication

Implantable Device Comprising External Mobilization Means For The Formation Of Articular Cartilage

EP4355271A1 · Palingen · Mar 18, 2026
Publication

Artemisinin Proteasome Inhibitor Conjugates And Their Use In The Treatment Of Disease

EP4281066A2 · Cornell University · Mar 18, 2026
Publication

Radioactive Halogen Labeled Precursor Compound

EP4282857A1 · Institute of Science Tokyo · Mar 18, 2026
Publication

Method For Dyeing Keratinous Material, Including The Application Of An Organosilicon Compound, Polyethylene Glycols, A Dyeing Compound, And An Aftertreatment Agent

EP4366688A1 · Henkel AG & Co. KGaA · Mar 18, 2026
Publication

Method For Dyeing Keratinous Material, Including The Application Of An Organosilicon Compound, A Dyeing Compound, A Sealing Reagent And An Alkaline Pre Treatment Agent

EP4366678A1 · Henkel AG & Co. KGaA · Mar 18, 2026
Publication

Circrnas For Gene Silencing

EP4347844A1 · Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. · Mar 18, 2026
Publication

Hydroxybisphosphonic Derivatives Of Meloxicam For The Treatment Of Inflammatory Joint Diseases

EP4330264A1 · Atlanthera · Mar 18, 2026
Publication

The Polarity And Specificity Of Sars Cov2 Specific T Lymphocyte Responses As A Biomarker Of Disease Susceptibility

EP4330674A1 · Institut Gustave-Roussy · Mar 18, 2026
Publication

Pyridine Sulfonamide Derivatives As Sigma Ligands

EP4330248A1 · Acondicionamiento Tarrasense · Mar 18, 2026
Publication

Microbial Glycolipids

EP4330265A1 · Analyticon Discovery GmbH · Mar 18, 2026
Publication

Dosing Regimens

EP4337205A1 · Novartis AG · Mar 18, 2026
Publication

Small Molecule Antagonists For The Relaxin 3/Rxfp3 System

EP4304630A1 · Research Triangle Institute · Mar 18, 2026
Publication

Branched Linkers For Antibody Drug Conjugates And Methods Of Use Thereof

EP4301415A1 · R.P. Scherer Technologies, LLC · Mar 18, 2026
Publication

Arylsulfoxamides As Orexin Receptor Agonists

EP4301728A1 · Research Triangle Institute · Mar 18, 2026
Publication

Vaccines For The Treatment And Prevention Of Zoonotic Infections

EP4301406A1 · Longhorn Vaccines and Diagnostics, LLC · Mar 18, 2026
Publication

Compositions And Methods For Enhancing Anti Viral Therapies

EP4301355A2 · XORTX Therapeutics Inc. · Mar 18, 2026
Publication

Iron Complex Compounds For Subcutaneous Use In Therapy Of Iron Deficiency In Companion Animals

EP4380581A1 · Pharmacosmos Holding A/S · Mar 18, 2026
Publication

Compositions And Methods For Treating Canine Parvovirus Infection

EP4297745A1 · MOXXITECH, LLC · Mar 18, 2026
Publication

Heteroaryl Derivatives As Apelin Receptor Agonists

EP4298091A1 · Research Triangle Institute · Mar 18, 2026
Publication

Composition, For Preventing, Relieving, Or Treating Disease Caused By Nitration Of Protein, Containing Peptide Having Tyrosine Located At Terminal As Active Ingredient

EP4298924A1 · Industry-Academic Cooperation Foundation Gyeongsang National University · Mar 18, 2026
Publication

Electrode Assembly For Applying Tumor Treating Fields With A Sheet Of Anisotropic Material

EP4344414A1 · Novocure GmbH · Mar 18, 2026
Publication

Controlled Release Coating Agent

EP4376810A1 · Nutrition & Biosciences USA 1, LLC · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4294790A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Systems, Devices, And Formulations For Time Phased Histamine Delivery

EP4294446A1 · Agonex Biopharmaceuticals, Inc. · Mar 18, 2026
Publication

Stable Isoquinoline Corticosteroid Conjugates And Uses Thereof

EP4330267A1 · Aerie Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Acetyl Sh Hexapeptide 5 Amide Acetate For Use In The Treatment Of Hair Loss Disorders And As A Hair Care Agent

EP4326305A1 · Laboratorio Genove, S.A. · Mar 18, 2026
Publication

Urea Derivatives For Treating Uveal Melanoma

EP4322944A1 · Centre National de la Recherche Scientifique · Mar 18, 2026
Publication

Cleansing Composition For Female Intimate Hygiene

EP4323071A1 · Unilever IP Holdings B.V. · Mar 18, 2026
Publication

Spirocyclic Imidazolidinones And Imidazolidinediones For Treatment Of Light Chain Amyloidosis

EP4326721A1 · Protego Biopharma, Inc. · Mar 18, 2026
Publication

Modulation Of Antibody Dependent Cellular Cytotoxicity

EP4326333A1 · Seagen Inc. · Mar 18, 2026
Publication

Methods And Compositions For Treatment Of Cystic Fibrosis

EP4323011A1 · Spirovant Sciences, Inc. · Mar 18, 2026
Publication

New Pyrazolo[1,5 A]Pyrimidine Derivatives As Sigma Ligands

EP4323363A1 · Acondicionamiento Tarrasense · Mar 18, 2026
Publication

Means And Methods For Enhancing Receptor Targeted Gene Transfer

EP4320244A1 · Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts · Mar 18, 2026
Publication

Cyclic Peptide Immunomodulators

EP4323380A2 · Bristol-Myers Squibb Company · Mar 18, 2026
Publication

Combination Product And Methods For Preventing The Emergence Of Antibiotic Resistant Bacteria Under Antibiotic Treatment

EP4329760A1 · Diotheris · Mar 18, 2026
Publication

Cosmetic Composition Comprising Hinokitiol

EP4319884A1 · Unilever IP Holdings B.V. · Mar 18, 2026
Publication

Wnt5 A Peptides For The Treatment Of Acute Myelogenous Leukemia

EP4346873A1 · Wntresearch AB · Mar 18, 2026
Publication

Individualized Cell Therapy Using Patient Derived Antigen Specific Regulatory T Cells

EP4373517A1 · Phaim Pharma Ltd · Mar 18, 2026
Publication

Camptothecine Antibody Drug Conjugates And Methods Of Use Thereof

EP4277629A1 · R.P. Scherer Technologies, LLC · Mar 18, 2026
Publication

Hair Care Compositions Comprising Hydroxylated Triglyceride Oligomers

EP4355288A1 · The Procter & Gamble Company · Mar 18, 2026
Publication

Unsaturated Hydroxamic Acid Derivatives And Their Use For The Treatment And Prevention Of An Ammonia Associated Disease Or Disorder

EP4362928A1 · Genfit · Mar 18, 2026
Publication

Combination Of Deoxyribonuclease Enzyme And Cell Therapies For Treatment Of Cancer

EP4274585A1 · CLS Therapeutics Limited · Mar 18, 2026
Publication

Substituted Salicylamide Compounds And Use Thereof

EP4277884A1 · Helios Huaming Biopharma Co., Ltd. · Mar 18, 2026
Publication

Probiotic Containing An L. Casei Strain And Its Uses In Malnutritional Situations

EP4351606A1 · Institut National de la Recherche pour l'Agriculture, l'Alimentation et l'Environnement · Mar 18, 2026
Publication

Aav8 Capsid Variants With Enhanced Liver Targeting

EP4330270A2 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Vedolizumab Formulation

EP4346899A1 · Polpharma Biologics S.A. · Mar 18, 2026
Publication

In Vivo Lentiviral Gene Therapy For The Treatment Of Primary Hyperoxaluria Type 1

EP4330415A1 · Centro de Investigaciones Energéticas, Medioambientales y Tecnológicas, O.A., M.P. · Mar 18, 2026
Publication

Carbon Based Antiviral Nanoparticles

EP4323426A1 · Porto Conte Ricerche Società A Responsabilità Limitata · Mar 18, 2026
Publication

Enantiomers Of Substituted Thiazoles As Antiviral Compounds

EP4209491A1 · Innovative Molecules GmbH · Mar 18, 2026
Publication

Early Detection Of Hepatocellular Carcinoma

EP4194003A1 · Drexel University · Mar 18, 2026
Publication

Subset Optimized Chimeric Antigen Receptor Containing Cells

EP4205749A1 · Novartis AG · Mar 18, 2026
Publication

Methods Of Producing Long Acting Ctp Modified Polypeptides

EP4212546A1 · OPKO Biologics Ltd. · Mar 18, 2026
Publication

Protein Comprising Nc 1 For Treating Angiogenesis Related Diseases

EP4215206A1 · Heidelberg Biotech GmbH · Mar 18, 2026
Publication

Composition Comprising Bifidobacterium Longum Strains Ncimb 41003 And Ncimb 41676 For Use In Treating Irritable Bowel Syndrome

EP4154722A1 · PrecisionBiotics Group Limited · Mar 18, 2026
Publication

Non Viral Dna Vectors Expressing Anti Coronavirus Antibodies And Uses Thereof

EP4329884A1 · Generation Bio Co. · Mar 18, 2026
Publication

Crosslinked Polymer Obtained By Polymerisation Of At Least One Particular Dicarboxylic Ethylenic Monomer In The Presence Of A Particular Diester Crosslinking Agent With Two Unsaturations

EP4326225A1 · DAITO KASEI EUROPE SAS · Mar 18, 2026
Publication

Nutritional Composition Comprising 2'fucosyllactose And Dietary Butyrate

EP4151097A1 · N.V. Nutricia · Mar 18, 2026
Publication

New Pharmaceutical Composition For Drug Delivery

EP4154866A1 · Orexo AB · Mar 18, 2026
Publication

Therapy For Inhibition Of Single Stranded Rna Virus Replication

EP4134076A1 · Redhill Biopharma Ltd. · Mar 18, 2026
Publication

Antibody Therapeutics That Bind Cd38

EP4180058A1 · Vivasor, Inc. · Mar 18, 2026
Publication

Liposomes And Its Use For Enzyme Delivery

EP4284342A1 · Consejo Superior De Investigaciones Científicas - CSIC · Mar 18, 2026
Publication

Dental Care Products

EP4277709A1 · Dr. Kurt Wolff GmbH & Co. KG · Mar 18, 2026
Publication

Acebutolol Hydrochloride For Use In Treating Psoriasis

EP4342462A1 · Sun, Liangdan · Mar 18, 2026
Publication

Heterocyclic Compounds As Ret Kinase Inhibitors

EP4104837A2 · Cancer Research Technology Limited · Mar 18, 2026
Publication

Pyrazolopyrimidine Compounds Useful As Ret Inhibitors

EP4105219A1 · Cancer Research Technology Limited · Mar 18, 2026
Publication

2,4 Diaminoquinazoline Derivatives And Medical Uses Thereof

EP4059924A1 · Janssen Sciences Ireland Unlimited Company · Mar 18, 2026
Publication

Implantable Or Injectable Products Based On Polymers And Method For Their Preparation

EP4301428A1 · Symatese · Mar 18, 2026
Publication

Treatment Of Overactive Bladder With Oxybutynin Applied By Means Of A Vaginal Ring

EP4297744A1 · Ligalli B.V. · Mar 18, 2026
Publication

Amiselimod For Preventing, Treating, Or Ameliorating Ulcerative Colitis

EP4288041A1 · Bausch Health Ireland Limited · Mar 18, 2026
Publication

Sunscreen Composition Based On Bemt And Two Or More Pigmentary Uv Filters

EP4288158A1 · DSM IP Assets B.V. · Mar 18, 2026
Publication

Products And Compositions

EP4219713A2 · Silence Therapeutics GmbH · Mar 18, 2026
Publication

Coupling Endonucleases With End Processing Enzymes Drives High Efficiency Gene Disruption

EP4062927A1 · Seattle Children's Research Institute · Mar 18, 2026
Publication

Antibodies Specifically Binding Pd 1 And Their Uses

EP4046655A1 · Janssen Biotech, Inc. · Mar 18, 2026
Publication

Compositions For Rejuvenating Skeletal Muscle Stem Cells

EP4140497A1 · President and Fellows of Harvard College · Mar 18, 2026
Publication

Rho Kinase Inhibitors

EP4116293A2 · Kadmon Corporation, LLC · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4271664A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Novel Modified Reovirus And Use Thereof

EP4268837A1 · Virocure, Inc. · Mar 18, 2026
Publication

Tnf Alpha And Ngf Antibodies For Veterinary Use

EP4263603A2 · Elanco US Inc. · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4259144A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4259128A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Tetrahydroquinazoline Derivatives As Selective Cytotoxic Agents

EP4259608A1 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Boronic Acid Compounds

EP4242213A1 · LG Chem, Ltd. · Mar 18, 2026
Publication

Peptide Receptor Radionuclide Therapy

EP4255891A1 · The Regents of University of California · Mar 18, 2026
Publication

Desmoglein 2 Directed Chimeric Antigen Receptor (Car) Constructs And Methods Of Use

EP4255484A1 · Thomas Jefferson University · Mar 18, 2026
Publication

Heterocyclic Derivatives As Janus Kinase Inhibitors

EP4308122A1 · Chiesi Farmaceutici S.p.A. · Mar 18, 2026
Publication

Oligonucleotide Ligand Conjugates And Process For Their Preparation

EP4039278A1 · Alnylam Pharmaceuticals, Inc. · Mar 18, 2026
Publication

1,4 Disubstituted Pyridazine Derivatives And Their Use For Treating Smn Deficiency Related Conditions

EP4105208A1 · Novartis AG · Mar 18, 2026
Publication

Biaryl Compositions And Methods For Modulating A Kinase Cascade

EP4063360A1 · Athenex, Inc. · Mar 18, 2026
Publication

Long Acting Compstatin Analogs And Uses Thereof

EP4105224A1 · Apellis Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Antibodies Binding Cd24, Preparation And Use Thereof

EP4166196A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Antibodies Binding Cd70, Preparation And Use Thereof

EP4166571A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Methods For Preventing Disulfide Bond Reduction In Cell Culture Harvest

EP4074340A1 · Bayer HealthCare LLC · Mar 18, 2026
Publication

Preparation And/Or Formulation Of Proteins Cross Linked With Polysaccharides

EP4043043A1 · Allergan Pharmaceuticals International Limited · Mar 18, 2026
Publication

Tyk2 Inhibitors And Uses Thereof

EP4019518A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Stable Composition Comprising A Honey And A Cannabinoid

EP4251182A1 · MW Pharma IP Limited · Mar 18, 2026
Publication

Anti Vegf Anti Pd L1 Bispecific Antibody, Pharmaceutical Composition Of Same, And Uses Thereof

EP4209513A1 · Biotheus Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Mesothelin Positive Cancers

EP4100028A1 · A2 Biotherapeutics, Inc. · Mar 18, 2026
Publication

Compounds For Prevention Or Treatment Of Neurodegenerative Disorders

EP4200299A1 · 1st Biotherapeutics, Inc. · Mar 18, 2026
Publication

Pyrimidinone Compounds And Uses Thereof

EP4200281A1 · Hutchison Medipharma Limited · Mar 18, 2026
Publication

Anti Cd73 Antibody And Use Thereof

EP4197555A1 · Akeso Biopharma, Inc. · Mar 18, 2026
Publication

Humanized Antibody, Chimeric Antigen Receptor, Nucleic Acid, Vector, Cell And Use

EP4190808A1 · Shenzhen Immunofoco Biotechnology Co., Ltd. · Mar 18, 2026
Publication

Proteasome Enhancers And Uses Thereof

EP4196121A1 · Board Of Trustees Of Michigan State University · Mar 18, 2026
Publication

Donepezil Ether Palmitate Or Pharmaceutically Acceptable Salt Thereof

EP4198021A1 · Chong Kun Dang Pharmaceutical Corp. · Mar 18, 2026
Publication

Compositions Comprising Ketotifen And A Non Steroidal Anti Inflammatory Drug Selected From Naproxen Or Indomethacin For Use In The Treatment Of A Beta Coronavirus Infection

EP4192457A1 · Sen-Jam Pharmaceutical LLC · Mar 18, 2026
Publication

Systems And Methods For Preservative Removal From Ophthalmic Formulations

EP4192405A1 · Tearclear Corp. · Mar 18, 2026
Publication

Inhibitors Of Short Chain Dehydrogenase Activity For Treating Neurodegeneration

EP4192455A1 · CASE WESTERN RESERVE UNIVERSITY · Mar 18, 2026
Publication

Therapeutic Targeting Of Phosphate Dysregulation In Cancer Via The Xpr1:Kidins220 Protein Complex

EP4192486A1 · The Broad Institute, Inc. · Mar 18, 2026
Publication

Polypeptides Rv3 And Rv4 Having Anti Aging Function And Applications Thereof

EP4190798A1 · Nanjing Anji Biological Technology Co., Ltd · Mar 18, 2026
Publication

Formulation Of Novel Bispecific Anti Cd3/Cd20 Polypeptide Complex

EP4190352A1 · CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. · Mar 18, 2026
Publication

Salt And Crystal Form Of Pyrimidine Compound, And Preparation Methods Therefor

EP4190781A1 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Compositions And Methods For Treating Bacterial Infections

EP4188424A1 · Mucpharm Pty Ltd · Mar 18, 2026
Publication

Antivirus Proteins Having A Kringle 5 Subunit

EP4319878A1 · CREATIVE BIOTHERAPEUTICS, LLC · Mar 18, 2026
Publication

Novel Bacteriophage Having Enterotoxigenic Escherichia Coli Specific Bactericidal Effect And Antibacterial Composition Comprising Same

EP4299725A1 · CJ Cheiljedang Corporation · Mar 18, 2026
Publication

Target Cell Restricted, Costimulatory, Bispecific And Bivalent Anti Cd28 Antibodies

EP4240762A1 · Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts · Mar 18, 2026
Publication

Linear Apelin Receptor Agonists

EP4225773A1 · Nxera Pharma UK Limited · Mar 18, 2026
Publication

Triple Combination Therapy For Enhancing Cancer Cell Killing In Cancers With Low Immunogenicity

EP4146216A1 · Beyondspring Pharmaceuticals Inc. · Mar 18, 2026
Publication

Irak Inhibitors And Uses Thereof

EP4142717A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Precision Dosing Regimen

EP4142755A1 · Children's Hospital Medical Center · Mar 18, 2026
Publication

Engineered Crispr Cas Systems And Methods For Sensitive And Specific Diagnostics

EP4143307A2 · Montana State University · Mar 18, 2026
Publication

Novel Therapy For Acute Damage To Lung Tissue

EP4138916A1 · Remodeless CV Ltd. · Mar 18, 2026
Publication

Single Variable Domain Antibody Targeting Human Programmed Death Ligand 1 (Pd L1) And Derivative Thereof

EP4144758A1 · Mabwell (Shanghai) Bioscience Co., Ltd. · Mar 18, 2026
Publication

Thiohydroxypyridine Chelates

EP4232029A1 · Lumiphore, Inc. · Mar 18, 2026
Publication

Double Degraders And Uses Thereof

EP4232059A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Proinflammatory Prodrugs

EP4232093A1 · THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM · Mar 18, 2026
Publication

Water In Oil Emulsifier Derived From Natural Sources

EP4213797A1 · HallStar Beauty and Personal Care Innovations Company · Mar 18, 2026
Publication

Liver Specific Production Of Enpp1 Or Enpp3

EP4225927A1 · Inozyme Pharma, Inc. · Mar 18, 2026
Publication

Bioerodible Ocular Drug Delivery Insert And Therapeutic Method

EP4210682A1 · EyePoint, Inc. · Mar 18, 2026
Publication

Cytokine Storm Inhibitor, Method For Using Cytokine Storm Inhibitor, And Method For Screening For Cytokine Inhibitor

EP4212163A1 · Dexon Pharmaceuticals Inc. · Mar 18, 2026
Publication

Chebulinic Acid And Its Enriched Fraction From The Fruits Of Terminalia Chebula For Treatment Of Benign Prostatic Hyperplasia (Bph) And Its Preparation Thereof

EP4210721A1 · Council of Scientific and Industrial Research · Mar 18, 2026
Publication

Recombinant Sars Cov 2 Spike Protein Subunits, Expression And Uses Thereof

EP4208198A2 · Hawaii Biotech, Inc. · Mar 18, 2026
Publication

Pharmaceutical Composition For Treatment Of Hypertrophic Cardiomyopathy And Treatment Method Using Same Composition

EP4140482A1 · Celltrion, Inc. · Mar 18, 2026
Publication

Water Soluble Formulations Containing Cannabinoids

EP4135770A1 · National Research Council of Canada · Mar 18, 2026
Publication

Combination Of A Sting Agonist And A Complex Comprising A Cell Penetrating Peptide, A Cargo And A Tlr Peptide Agonist

EP4228681A1 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Treating Autoimmune Diseases With Genetically Modified Cells

EP4132545A1 · Wallkill Biopharma, Inc. · Mar 18, 2026
Publication

Compositions Comprising Nanoparticles, Method Of Making And Uses Thereof

EP4132548A1 · Organicell Regenerative Medicine, Inc. · Mar 18, 2026
Publication

Methods And Compositions For Preventing And Treating Retinal Nerve Damage

EP4132537A1 · G3P, Inc. · Mar 18, 2026
Publication

Oral Care Compositions

EP4188317A1 · Colgate-Palmolive Company · Mar 18, 2026
Publication

Octahydropyrazinodiazanaphthyridine Dione Compounds

EP4129997A1 · Medshine Discovery Inc. · Mar 18, 2026
Publication

Methods And Treatment Involving Excess Free Light

EP4126945A2 · Avalo Therapeutics, Inc. · Mar 18, 2026
Publication

Administration Of Sting Agonist, Checkpoint Inhibitors, And Radiation

EP4247385A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Method For Detecting An Analyte Of Interest In A Sample

EP4267961A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Amorphous Solid Dispersions

EP4262756A1 · UCB Biopharma SRL · Mar 18, 2026
Publication

Multi Parallel Analysis Of T Cell Therapies

EP4178590A1 · The Board of Trustees of the Leland Stanford Junior University · Mar 18, 2026
Publication

New Aryl Pyrido Pyrimidin One Derivatives

EP4263541A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Pharmaceutical Compositions Of 6 (2 (2 H Tetrazol 5 Yl)ethyl) 6 Fluorodecahydroisoquinoline 3 Carboxylic Acid And Ester Derivatives Thereof

EP4175635A1 · Sea Pharmaceuticals LLC · Mar 18, 2026
Publication

Compositions And Methods For Modulating Hair Growth

EP4172159A1 · The Regents of the University of California · Mar 18, 2026
Publication

Reduction Of Rancidity Of Vegetable Oils

EP4259079A1 · TotalEnergies OneTech · Mar 18, 2026
Publication

Increased Solubilization Of Diethylamino Hydroxybenzoyl Hexyl Benzoate

EP4259076A1 · TotalEnergies OneTech · Mar 18, 2026
Publication

Imiquimod Cocrystals

EP4167975A1 · CELISTA PHARMACEUTICALS LLC · Mar 18, 2026
Publication

Use Of Palovarotene In Treatment Against Hbv Virus

EP4186505A1 · Yang Sheng Tang Company, Ltd. · Mar 18, 2026
Publication

Anhydrous Solid Shampoo Based On Surfactants And On A Fatty Acid Salt, Its Method Of Preparation And A Kit

EP4255582A1 · L'OREAL · Mar 18, 2026
Publication

Crystalline Forms Of Irak Degraders

EP4161575A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Deuterated Irak Degraders And Uses Thereof

EP4161521A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Antibody Drug Conjugates

EP4240488A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Piperidine 2,6 Diones As Small Molecule Degraders Of Helios And Methods Of Use

EP4153175A1 · Dana-Farber Cancer Institute, Inc. · Mar 18, 2026
Publication

A Process For Preparing A Pharmaceutical Preparation

EP4251184A1 · Dr Dozo Laboratories · Mar 18, 2026
Publication

Enriched Bioactive Renal Cell Populations, Characteristics And Uses Thereof

EP4243837A1 · Bertram, Timothy, A. · Mar 18, 2026
Publication

Recombinant Adeno Associated Viruses With Enhanced Liver Tropism And Uses Thereof

EP4244360A1 · Beijing SoloBio Genetechnology Company Ltd. · Mar 18, 2026
Publication

Polypeptides For Use In The Treatment And Prevention Of Neurodegenerative Diseases

EP4232066A1 · Immune System Key Ltd. · Mar 18, 2026
Publication

Pharmaceutical Compositions And Methods Of Using The Same For Treating Cancer

EP4237094A1 · Otsuka Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Cinnamein Composition For Use In The Treatment Of Urea Cycle Disorders

EP4236966A1 · Rush University Medical Center · Mar 18, 2026
Publication

Method And Drug For Promoting Degradation Of Misfolded Protein And Aggregate Thereof

EP4122489A1 · Talengen International Limited · Mar 18, 2026
Publication

Isotopically Labelled Trapidil Derivatives

EP4125853A1 · Sinopia Biosciences, Inc. · Mar 18, 2026
Publication

Treatment Of Inflammatory Diseases With Peptides And Pharmaceutical Compositions

EP4114430A2 · YUYU Pharma, Inc. · Mar 18, 2026
Publication

Mdm2 Degraders And Uses Thereof

EP4121043A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Solid Composition Comprising The Combination Of At Least Two Particular Anionic Surfactants

EP4210654A1 · L'OREAL · Mar 18, 2026
Publication

Effervescent Formulation Containing Apoaequorin

EP4199901A1 · Quincy Bioscience, LLC · Mar 18, 2026
Publication

Combination Of Merestinib With Ly2584702 For The Treatment Of Glioblastoma

EP4117787A1 · University of Cincinnati · Mar 18, 2026
Publication

Compositions Derived From Salvia Hispanica Seeds

EP4114425A1 · Signum Biosciences, Inc. · Mar 18, 2026
Publication

Ferroptosis Inhibitors Diarylamine Para Acetamides

EP4114375A1 · Sironax Ltd. · Mar 18, 2026
Publication

Method Of Producing A Metal Nanoparticle

EP4204144A1 · Metalchemy Limited · Mar 18, 2026
Publication

Ketorolac For Use In The Treatment Of Cytokine Storm And Cytokine Release Syndrome

EP4110329A1 · Yinuoke Medicine Science Technology Company Ltd. · Mar 18, 2026
Publication

Anti Tumor Composition

EP4112065A1 · SPH Sine Pharmaceutical Laboratories Co., Ltd · Mar 18, 2026
Publication

Chemically Modified Transfer Rna Derived Small Rnas (Tsrnas) To Target Pathogenic Bacteria

EP4110921A1 · ADA Forsyth Institute, Inc. · Mar 18, 2026
Publication

Increased Solubilization Of Ethylhexyl Triazone

EP4259074A2 · TotalEnergies OneTech · Mar 18, 2026
Publication

Estolide Esters For The Cosmetic Treatment Of Skin

EP4255381A1 · Clariant International Ltd · Mar 18, 2026
Publication

Diamine Linked Receptor Specific Cyclic Peptides

EP4100040A1 · Boehringer Ingelheim International GmbH · Mar 18, 2026
Publication

Pharmaceutical Use Of Ketoamide Based Compound

EP4098258A1 · Shanghai Institute of Materia Medica, Chinese Academy of Sciences · Mar 18, 2026
Publication

Compounds And Uses Thereof

EP4096668A1 · Foghorn Therapeutics Inc. · Mar 18, 2026
Publication

Indazole Derivatives As Cannabanoid Receptor Partial Agonists

EP4097088A1 · Research Triangle Institute · Mar 18, 2026
Publication

Use Of Rhodococcus Ruber Cell Wall Skeleton In Regenerative Medicine

EP4043555A1 · Liaoning Greatest Bio-Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Pharmaceutical Composition For Preventing Or Treating Alzheimer's And Use Thereof

EP4091635A1 · Toolgen Incorporated · Mar 18, 2026
Publication

Controlled Release Granulations Of Water Soluble Active Pharmaceutical Ingredients

EP4167971A1 · XWPharma Ltd. · Mar 18, 2026
Publication

Combination Cancer Therapy Using Chk Inhibitor

EP4087563A1 · Shanghai Huayu Biotechnology Co., Ltd. · Mar 18, 2026
Publication

Vaccine Against Human Pathogenic Coronaviruses

EP4138899A2 · ACM Biolabs Pte Ltd · Mar 18, 2026
Publication

Cycloalkyl Pyrimidines As Ferroportin Inhibitors

EP4143178A1 · Global Blood Therapeutics, Inc. · Mar 18, 2026
Publication

(S) 2 Amino 6 ((3 Aminopropyl)amino)hexanoic Acid (Apl) For Use In The Treatment Of Non Alcoholic Steatohepatitis (Nash), Liver Inflammation, Hepatocellular Ballooning, Liver Fibrosis And Steatosis

EP4138812A1 · Temple University - Of The Commonwealth System of Higher Education · Mar 18, 2026
Publication

Cosmetic Composition Based On Biosourced Isododecane And Preparation Method Thereof

EP4149413A1 · Global Bioenergies · Mar 18, 2026
Publication

Method Of Selecting Patients For Treatment With A Combination Of An Axl Inhibitor And An Immune Checkpoint Modulator

EP4138823A1 · BerGenBio ASA · Mar 18, 2026
Publication

Azalactam Compounds As Hpk1 Inhibitors

EP4143186A1 · Pfizer Inc. · Mar 18, 2026
Publication

Composition For Improving Cognitive Function

EP4135676A1 · Activ'Inside · Mar 18, 2026
Publication

Pd 1 Specific Antisense Oligonucleotide And Its Use In Therapy

EP4143318A1 · Secarna Pharmaceuticals GmbH & Co. KG · Mar 18, 2026
Publication

New Triazinoindole Compounds

EP4143192A1 · JANSSEN Pharmaceutica NV · Mar 18, 2026
Publication

Bicyclic Kinase Inhibitors And Uses Thereof

EP4143191A2 · iOmx Therapeutics AG · Mar 18, 2026
Publication

Tablet Pharmaceutical Formulations

EP4138787A1 · Astrazeneca AB · Mar 18, 2026
Publication

Furin Inhibitors For Treating Coronavirus Infections

EP4125897A1 · BP Asset V, Inc. · Mar 18, 2026
Publication

N (Heterocyclyl And Heterocyclylalkyl) 3 Benzylpyridin 2 Amine Derivatives As Sstr4 Agonists

EP4126849A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Novel Combination For The Treatment Of Aids

EP4138910A1 · 21C BIO · Mar 18, 2026
Publication

Immunization Against Sars Cov Related Diseases

EP4138876A1 · ISA Pharmaceuticals B.V. · Mar 18, 2026
Publication

Antibody Molecule Drug Conjugates And Uses Thereof

EP4126064A1 · Visterra, Inc. · Mar 18, 2026
Publication

A Composition Comprising Lactobacillus Strains For Treating Or Preventing Conditions Of Elevated Serum Urate

EP4185309A1 · Beo Therapeutics · Mar 18, 2026
Publication

Preterm Labour With Prostaglandin E2 Receptor Agonists

EP4188354A1 · Imperial College Innovations Limited · Mar 18, 2026
Publication

Coronavirus Vaccine

EP4138897A1 · BioNTech SE · Mar 18, 2026
Publication

Topical Roflumilast Formulation Having Improved Delivery And Plasma Half Life

EP4096630A1 · Arcutis Biotherapeutics, Inc. · Mar 18, 2026
Publication

Compositions Comprising Luffa Cylindrica Root Extract

EP4110278A1 · Clariant International Ltd · Mar 18, 2026
Publication

Alk5 Inhibitor Conjugates And Uses Thereof

EP4087657A1 · Synthis Therapeutics, Inc. · Mar 18, 2026
Publication

Substituted Triazinones As Thyroid Hormone Receptor Agonists

EP4090652A1 · Eccogene Inc. · Mar 18, 2026
Publication

Treatment Of Membranous Nephropathy, Igg4 Related Disease, And Antiphospholipid Syndrome Using Btk Inhibitor 2 [(3 R) 3 [4 Amino 3 (2 Fluoro 4 Phenoxy Phenyl)pyrazolo[3,4 D]Pyrimidin 1 Yl]Piperidine 1 Carbonyl] 4 Methyl 4 [4 (Oxetan 3 Yl)piperazin 1 Yl]Pent 2 Enenitrile

EP4087577A1 · Principia Biopharma Inc. · Mar 18, 2026
Publication

Testosterone Containing Pharmaceutical Composition

EP4065126A1 · Neurocrine UK Limited · Mar 18, 2026
Publication

Pharmaceutical Compositions Comprising Bictegravir

EP4153181A1 · GILEAD SCIENCES, INC. · Mar 18, 2026
Publication

P38 Alpha Mitogen Activated Protein Kinase Inhibitors

EP4153303A1 · GEN1E Lifesciences Inc. · Mar 18, 2026
Publication

Use Of Trehalose As Prebiotic For Inhibiting Ailment Inducing Microorganisms

EP4178528A1 · Unilever IP Holdings B.V. · Mar 18, 2026
Publication

Cooling Personal Care Composition Comprising A Polyol And A Polyoxyehtylene Polyoxypropylene Block Copolymer

EP4161483A1 · Unilever IP Holdings B.V. · Mar 18, 2026
Publication

Anti Cd40 Antibody Combination Treatment For Cancer

EP4143230A1 · Seagen Inc. · Mar 18, 2026
Publication

Antibody Drug Conjugates (Adcs) Comprising An Anti Trop 2 Antibody, Compositions Comprising Such Adcs, As Well As Methods Of Making And Using The Same

EP4146283A1 · Levena (Suzhou) Biopharma Co., Ltd. · Mar 18, 2026
Publication

Use Of A Mixture Of Lauroyl Macrogolglyceride And Polyethylene Glycol As A Carrier

EP3950001A1 · GATTEFOSSE SAS · Mar 18, 2026
Publication

Compositions For Use In Modulating The Gut Microbiota And Managing Weight

EP3915552A1 · Lpoxy Therapeutics, Inc. · Mar 18, 2026
Publication

Immunoassay Of S Adenosylmethionine Using Analogs Thereof And Personalized Therapeutics

EP3915584A2 · Hao, Xiujuan · Mar 18, 2026
Publication

Use Of Small Molecules To Enhance Mafa Expression In Pancreatic Endocrine Cells

EP3954759A1 · Janssen Biotech, Inc. · Mar 18, 2026
Publication

Hyaluronic Acid Based Gels Including Lidocaine

EP3988082A1 · Allergan Industrie, SAS · Mar 18, 2026
Publication

Drug Related Transgene Expression

EP3943507A1 · Seattle Children's Hospital, dba Seattle Children's Research Institute · Mar 18, 2026
Publication

Orodispersible Effervescent Tablet Comprising Budesonide For Use In The Treatment Of Eosinophilic Esophagitis

EP4091615A1 · Dr. Falk Pharma GmbH · Mar 18, 2026
Publication

Method For Inducing Antitumor Immunity Using Sindbis Viral Vectors And Tumor Associated Antigens

EP3925619A1 · New York University · Mar 18, 2026
Publication

Phospholipids And Phospholipid Metabolites For Treating Viral And Bacterial Pneumonia And Sepsis

EP4135714A1 · Massing, Ulrich · Mar 18, 2026
Publication

Particles, Dna & Rna

EP4136218A1 · Novoscope IP Limited · Mar 18, 2026
Publication

Treating Pulmonary Inflammatory Disease Associated With Covid 19 By Administering Resiniferatoxin

EP4125871A1 · Vivasor, Inc. · Mar 18, 2026
Publication

Pharmaceutical Composition For Treating Inflammatory Bowel Diseases

EP4132473A1 · Cvasthera · Mar 18, 2026
Publication

Ophthalmic Formulation Comprising N [5 (Aminosulfonyl) 4 Methyl 1,3 Thiazol 2 Yl] N Methyl 2 [4 (2 Pyridinyl)phenyl]Acetamide Hemihydrate

EP4096632A1 · AIC316 GmbH · Mar 18, 2026
Publication

Antiviral And Antimicrobial Fabric Treatment As Well As Fabrics Treated Therewith

EP4127304A1 · HeiQ Materials AG · Mar 18, 2026
Publication

Vaccine Compositions For Preventing Coronavirus Disease

EP4106809A1 · International AIDS Vaccine Initiative, Inc. · Mar 18, 2026
Publication

Cosmetic Formulations With An Argon Blanket And An Internal Argon Reservoir And Methods For Making Same

EP4139213A1 · TARAMAR SEEDS EHF. · Mar 18, 2026
Publication

Pharmaceutical Compositions Of A Therapeutic Polyene Macrolide And Methods Of Their Use

EP4110305A1 · Biosergen AS · Mar 18, 2026
Publication

Natural Composition Based On Polymers To Be Electrospun, And Method To Prepare The Same

EP4103769A1 · Bakel S.P.A. · Mar 18, 2026
Publication

Peptides As Selective Gip Receptor Agonists

EP4110800A1 · SANOFI · Mar 18, 2026
Publication

Macrocyclic Pad4 Inhibitors Useful As Immunosuppressant

EP4100405A1 · Bristol-Myers Squibb Company · Mar 18, 2026
Publication

Peritoneal Dialysis Solution For Hypertensive Subjects

EP4029507A1 · Iperboreal Pharma Srl · Mar 18, 2026
Publication

Trop2 Targeting Antibody Drug Conjugate, And Preparation Method And Use Therefor

EP4265275A1 · Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Peptides And Uses Thereof

EP4132957A1 · Sintica Biotech Societa a Responsabilita Limitata Semplificata · Mar 18, 2026
Publication

Polypeptide

EP4133084A1 · Autolus Limited · Mar 18, 2026
Publication

Process For The Treatment Of Keratin Fibers Employing A Composition Comprising At Least One Alkoxysilane Of Formula (I), At Least One Non Amino Silicone Of Formula (Ii) Having A Weight Average Molecular Weight Of Less Than Or Equal To 1500 G/Mol And At Least One Coloring Agent

EP4138774A1 · L'OREAL · Mar 18, 2026
Publication

Combination Treatment For Cancer Based Upon An Icos Antibody And A Pd L1 Antibody Tgf Beta Receptor Fusion Protein

EP4136105A1 · GlaxoSmithKline Intellectual Property Development Limited · Mar 18, 2026
Publication

Combination Treatment For Cancer Involving Anti Icos And Anti Pd1 Antibodies, Optionally Further Involving Anti Tim3 Antibodies

EP4136113A1 · GlaxoSmithKline Intellectual Property Development Limited · Mar 18, 2026
Publication

Anti Cd30 Chimeric Antigen Receptor And Its Use

EP3995512A1 · Abken, Hinrich · Mar 18, 2026
Publication

Flavagline Derivatives

EP3998257A1 · PIERRE FABRE MEDICAMENT · Mar 18, 2026
Publication

Combination Therapy For Use In The Treatment Of Patients Having Acute And/Or Persistent Dyspnea

EP4023218A1 · S-Form Pharma · Mar 18, 2026
Publication

Formulations Of Polyalkylene Oxide Asparaginase And Methods Of Making And Using The Same

EP4019007A1 · Servier IP UK Limited · Mar 18, 2026
Publication

1,2,4 Oxadiazole And Thiadiazole Compounds As Immunomodulators

EP4023645A1 · Aurigene Oncology Limited · Mar 18, 2026
Publication

Compounds And Compositions As Inhibitors Of Endosomal Toll Like Receptors

EP4059934A1 · Novartis AG · Mar 18, 2026
Publication

Recombinant Fusion Proteins Targeting Cd47 And Pd L1, Preparation And Use Thereof

EP4151229A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Improved Cell Compositions And Methods For Cancer Therapy

EP4101461A1 · Hadasit Medical Research Services and Development Ltd. · Mar 18, 2026
Publication

Polyvalent Derivatives Of Emoxypine

EP3920921A1 · Riesner Verwaltungs GmbH · Mar 18, 2026
Publication

Methods For Using Transcription Dependent Directed Evolution Of Aav Capsids

EP3917566A1 · Oregon Health & Science University · Mar 18, 2026
Publication

Microencapsulation With Potato Proteins

EP3914285A1 · International Flavors & Fragrances Inc. · Mar 18, 2026
Publication

Method For Dyeing Keratinous Material, Comprising The Use Of An Organosilicon Compound, A Colored Effect Pigment And A Sealing Reagent

EP3999017A1 · Henkel AG & Co. KGaA · Mar 18, 2026
Publication

Small Molecule Analogs Of The Protein E4 Orf1 In The Treatment And Prevention Of Metabolic Disorders

EP3908308A1 · Texas Tech University System · Mar 18, 2026
Publication

Small Molecule Degraders Of Fkbp12 Via Recruitment Of Von Hippel Lindau E3 Ubiquitin Ligase (Vhl) E3 Ubiquitin Ligase, And Uses In Dtag Systems

EP3908291A1 · Dana-Farber Cancer Institute, Inc. · Mar 18, 2026
Publication

Method For Dyeing Keratinous Material, Comprising The Use Of An Organosilicon Compound, A Colored Effect Pigment And A Film Forming Polymer

EP3999189A1 · Henkel AG & Co. KGaA · Mar 18, 2026
Publication

Pharmaceutical Composition Comprising A Colloidal Dispersion And Methods And Uses Thereof

EP3989948A1 · PREBONA AB · Mar 18, 2026
Publication

Compositions And Methods For Treating Gluten Intolerance And Disorders Arising Therefrom

EP3943104A1 · Codexis, Inc. · Mar 18, 2026
Publication

Plant Srna Extract For Use As An Immunosuppressive Agent

EP3907288A1 · Fondazione Edmund Mach · Mar 18, 2026
Publication

Aav Vectors For Retinal And Cns Gene Therapy

EP3913061A1 · Genzyme Corporation · Mar 18, 2026
Publication

Multivalent Pcv2 Immunogenic Compositions And Methods Of Producing Such Compositions

EP3868400A1 · Boehringer Ingelheim Animal Health USA Inc. · Mar 18, 2026
Publication

Sterile Therapeutic Composition Formulated For Enteral Administration Comprising One Or More Amino Acids For Use In Treating Dehydration Associated With Injury To The Small Intestine

EP3970715A1 · University of Florida Research Foundation, Inc. · Mar 18, 2026
Publication

Molecules With Altered Neonate Fc Receptor Binding Having Enhanced Therapeutic And Diagnostic Properties

EP3888690A2 · MedImmune, LLC · Mar 18, 2026
Publication

Immunogenic Composition And Vaccine Containing Chlamydia Ssp. Surface Antigens And Its Use

EP4032545A1 · Medizinische Hochschule Hannover · Mar 18, 2026
Publication

Novel Hydrogels

EP3994202A1 · INM - Leibniz-Institut für Neue Materialien gemeinnützige GmbH · Mar 18, 2026
Publication

Reservoir Configuration For An Aerosol Delivery Device

EP3972434A1 · RAI Strategic Holdings, Inc. · Mar 18, 2026
Publication

Car T Cells Targeting Bcma And Uses Thereof

EP3962949A1 · Celyad S.A. · Mar 18, 2026
Publication

3 Amino 4 H Benzo[E][1,2,4]Thiadiazine 1,1 Dioxide Derivatives As Inhibitors Of Mrgx2

EP3962901A1 · Solent Therapeutics, LLC · Mar 18, 2026
Publication

Polymer Oil Blend

EP3962446A1 · Dow Global Technologies LLC · Mar 18, 2026
Publication

Systems And Methods For Producing Baculoviral Infected Insect Cells (Biics) In Bioreactors

EP3962536A1 · Voyager Therapeutics, Inc. · Mar 18, 2026
Publication

Self Assembled Nano Fibers As Hemostatic Agent

EP3937952A1 · National Institute of Technology Rourkela · Mar 18, 2026
Publication

Composition Comprising Citrate And Carnitine Able To Activate The Production Of The Protein Klotho

EP3976006A1 · Iperboreal Pharma Srl · Mar 18, 2026
Publication

Hydrophilic Silica/Polymer Blend

EP3962445A1 · Dow Global Technologies LLC · Mar 18, 2026
Publication

Methods And Compositions For Inducing Autophagy

EP4135693A1 · Cartesian Therapeutics, Inc. · Mar 18, 2026
Publication

Inhibitors Of Human Immunodeficiency Virus Replication

EP3962603A1 · ViiV Healthcare UK (No.5) Limited · Mar 18, 2026
Publication

Solid Hair Conditioning Compositions

EP3996656A1 · Henkel AG & Co. KGaA · Mar 18, 2026
Publication

Method For Dyeing Keratinous Material By Means Of A Premix Of Aminosilicone And A Chromophoric Compound

EP3986362A1 · Henkel AG & Co. KGaA · Mar 18, 2026
Publication

Aqueous Cosmetic Preparation Containing Dispersed Wax Particles

EP3965719A1 · Beiersdorf AG · Mar 18, 2026
Publication

Drug Adsorbed Highly Porous Activated Carbon For Enhanced Drug Delivery

EP3952841A1 · THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS · Mar 18, 2026
Publication

Isopropylcarbonate Benzoyl Peroxide Compositions And Methods Of Use

EP3946597A1 · Galderma Holding SA · Mar 18, 2026
Publication

Novel Compounds And Therapeutic Uses Thereof

EP3947417A1 · Centauri Therapeutics Limited · Mar 18, 2026
Publication

Compositions Comprising Deuterated Heterocyclic Gamma Carboline And Their Use In The Treatment Or Prophylaxis Of A Central Nervous System Disorder

EP3888656A1 · Intra-Cellular Therapies, Inc. · Mar 18, 2026
Publication

Retroviral And Lentiviral Vectors

EP3904523A1 · Autolus Limited · Mar 18, 2026
Publication

Gene Delivery Systems For Treatment Of Heart Failure

EP4058584A1 · Icahn School of Medicine at Mount Sinai · Mar 18, 2026
Publication

Anti Fungal Compositions And Methods For Using Same

EP4058066A1 · The Research Foundation for The State University of New York · Mar 18, 2026
Publication

Tyk2 Pseudokinase Ligands

EP4054581A1 · Ventyx Biosciences, Inc. · Mar 18, 2026
Publication

Charged Ion Channel Blockers And Methods For Use

EP4054559A1 · Nocion Therapeutics, Inc. · Mar 18, 2026
Publication

Chimeric Proteins For Selective Lysis Of Bacteria

EP4051243A2 · Bactoclear Holdings Pte. Ltd. · Mar 18, 2026
Publication

Chimeric Antigen Receptors Against Human Cytomegalovirus

EP4041257A1 · The Regents of the University of California · Mar 18, 2026
Publication

Treatment For Gastrointestinal Disorders

EP4040991A1 · Mayo Foundation for Medical Education and Research · Mar 18, 2026
Publication

Cannabidiol Enhanced Probiotic Compositions And Uses Thereof For Treatment Of Infections

EP4041222A1 · Buzzelet Development And Technologies Ltd · Mar 18, 2026
Publication

Biomarker Based Treatment Of Focal Segmental Glomerulosclerosis And Diabetic Kidney Disease

EP4037680A1 · GFB (ABC), LLC · Mar 18, 2026
Publication

Phosphodiesterase Inhibitors And Use

EP4034094A1 · Zenshine Pharmaceuticals (Nanjing) Group Co., Ltd. · Mar 18, 2026
Publication

Treatment Of Egfr Mutant Related Cancers Using A Combination Of Egfr And Cdk4/6 Inhibitors

EP4034121A1 · Beta Pharma, Inc. · Mar 18, 2026
Publication

Tough Gel Based Drug Delivery Compositions And Methods Thereof

EP4031131A1 · President and Fellows of Harvard College · Mar 18, 2026
Publication

Devices And Methods For Modulating Adma In Blood

EP4028071A1 · The Trustees of Indiana University · Mar 18, 2026
Publication

Hydratable Compositions Comprising Macroparticles And Methods Of Making Them

EP4027949A1 · Warsaw Orthopedic, Inc. · Mar 18, 2026
Publication

Anti Fibrotic Compounds And Use Thereof

EP4025559A1 · Hadasit Medical Research Services and Development Ltd. · Mar 18, 2026
Publication

Pentapeptide And Methods Of Use Thereof

EP4065171A1 · THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS · Mar 18, 2026
Publication

Pharmaceutically Active Pyrazolo Pyridone Modulators Of Dcn1/2 Mediated Cullin Neddylation

EP3986893A1 · University Of Kentucky Research Foundation · Mar 18, 2026
Publication

Composition For Lice Control

EP4075981A1 · Intervet International B.V. · Mar 18, 2026
Publication

Pulrodemstat For Use In The Treatment Of Cancer By Targeting Cold Tumors

EP3983016A1 · Celgene Corporation · Mar 18, 2026
Publication

Synthesis Of Meldrum's Acid Derivatives For Use As Anti Uva And Anti Blue Light Agent

EP4061322A1 · Institut des Sciences et Industries du Vivant et de l'Environnement - AgroParisTech · Mar 18, 2026
Publication

Solid Personal Care Product And Production Method Thereof

EP4091600A1 · Blisspack Co., Ltd. · Mar 18, 2026
Publication

Smarca Degraders And Uses Thereof

EP4081308A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4076524A2 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4076536A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4076520A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP4072591A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Histone Deacytlase 6 Modulation Of Titin Protein Mediated Cardiac Tissue Stiffness And Method For Same

EP4069364A2 · The Regents of the University of Colorado, a body corporate · Mar 18, 2026
Publication

Compositions And Methods For Immunotherapy

EP4058035A1 · Ludwig Institute for Cancer Research Ltd · Mar 18, 2026
Publication

Anti Tnf Alpha Humanized Monoclonal Antibody Tcx060 Having Low Immunogenicity And Low Adcc/Cdc Function, And Use Thereof

EP3967708A1 · Abmax Biopharmaceuticals · Mar 18, 2026
Publication

Benzothiophene Compound, Preparation Method Therefor And Use Thereof

EP3964504A1 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Avapritinib For Use In The Treatment Of Eosinophilic Disorders

EP4041244A1 · Blueprint Medicines Corporation · Mar 18, 2026
Publication

Bromodomain Inhibitors

EP4051383A1 · Rheinisch-Westfälische Technische Hochschule (RWTH) Aachen · Mar 18, 2026
Publication

Bicyclic Peptide Ligand Drug Conjugates

EP4045089A1 · BicycleTX Limited · Mar 18, 2026
Publication

Degraders Of Cyclin Dependent Kinase 12 (Cdk12) And Uses Thereof

EP3958861A1 · Dana-Farber Cancer Institute, Inc. · Mar 18, 2026
Publication

Silicon Ion Complex Organized With Carboxylic Acid, Method For Manufacturing Complex, And Product Using Same

EP3960714A1 · Korea New Technology Co.,Ltd. · Mar 18, 2026
Publication

Cerium (Iii) Carbonate Formulations

EP3958984A1 · The Regents of the University of California · Mar 18, 2026
Publication

Flagellin Fusion Protein And Use Thereof

EP3960756A1 · Industry Foundation of Chonnam National University · Mar 18, 2026
Publication

Oligonucleotides Targeted To Pnpla3 For Use In A Method Of Treating A Liver Disease

EP4045062A1 · Astrazeneca AB · Mar 18, 2026
Publication

Methods Of Producing Extracellular Vesicles

EP4034276A1 · Lonza Sales AG · Mar 18, 2026
Publication

Plant Messenger Packs Encapsulating Polypeptides And Uses Thereof

EP3955896A1 · Flagship Pioneering Innovations VI, LLC · Mar 18, 2026
Publication

Unraveling Receptor Metabolite Interactions In The Human Microbiome

EP3955938A1 · The Rockefeller University · Mar 18, 2026
Publication

A Class Of Bifunctional Chimeric Heterocyclic Compounds For Targeted Degradation Of Androgen Receptors And Use Thereof

EP3957633A1 · Hinova Pharmaceuticals Inc. · Mar 18, 2026
Publication

A Method Of Altering A Differentiation Status Of A Cell

EP3953452A2 · Agency for Science, Technology and Research · Mar 18, 2026
Publication

Hydrogels And Methods Of Using The Same

EP3937941A2 · The Regents of the University of California · Mar 18, 2026
Publication

Methods For Treatment Of Niemann Pick Disease Type C

EP3952859A1 · Loma Linda University · Mar 18, 2026
Publication

Prevention Of Stress Induced Fear And Depressive Like Behavior With Serotonin 4 Receptor Agonists

EP3952852A1 · The Trustees of Columbia University in the City of New York · Mar 18, 2026
Publication

Product For Therapy And Methods

EP4031653A1 · The University of Bristol · Mar 18, 2026
Publication

Stat Degraders And Uses Thereof

EP3946360A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Devices And Methods For Delivery Of Substances Within A Prefilled Syringe

EP4009936A1 · Kaleo, Inc. · Mar 18, 2026
Publication

Nonpeptide Somatostatin Type 5 Receptor Agonists And Uses Thereof

EP4013748A1 · Crinetics Pharmaceuticals, Inc. · Mar 18, 2026
Publication

A Personal Care Composition

EP4009939A1 · Fine Organic Industries Limited · Mar 18, 2026
Publication

Heterocyclic Compound

EP4005637A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Use Of A Birnavirus Alone Or In Combination Therapy For The Treatment Of A Disease Caused By A Nidovirus

EP4263810A1 · ProBioGen AG · Mar 18, 2026
Publication

A Method For Fighting Microorganisms Using Menthol Derivatives

EP4259287A1 · Symrise AG · Mar 18, 2026
Publication

Factor H Potentiating Antibodies And Uses Thereof

EP3999073A1 · Gemini Therapeutics Sub, Inc. · Mar 18, 2026
Publication

Transdermal Solvent System And Methods Of Use

EP3999032A1 · Donaghys Limited · Mar 18, 2026
Publication

Stable Composition Comprising Combination Of Specific Ingredients

EP4076370A1 · L'OREAL · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP3989966A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Cannabinoid Conjugate Molecules

EP3986389A1 · Diverse Biotech, Inc. · Mar 18, 2026
Publication

Modified Hemoglobin Molecules And Uses Thereof

EP3946431A1 · University of Pittsburgh - of the Commonwealth System of Higher Education · Mar 18, 2026
Publication

Methods And Compositions For Treating Dysbiosis Of Oral Microbiome

EP3946393A1 · Aveta Biomics, Inc. · Mar 18, 2026
Publication

Immune Cell Containing Tumor Antigen Recognition Receptor And Application Thereof

EP3964568A1 · Shanghai Pharmaceuticals Holding Co., Ltd. · Mar 18, 2026
Publication

Spinel Glass Ceramic, Method For The Production Thereof And Shaped Dental Product Containing The Spinel Glass Ceramic

EP4031503A1 · Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. · Mar 18, 2026
Publication

Liquid Composition Comprising Antibody Of Human Interleukin 4 Receptor Alpha

EP3939609A1 · Connect Biopharma HongKong Limited · Mar 18, 2026
Publication

Cell Encapsulation Devices

EP3938001A1 · Encellin, Inc. · Mar 18, 2026
Publication

Method For Selecting Subject Likely Benefiting From Pharmaceutical Composition For Treating Or Preventing Cancer

EP3932491A1 · International Institute of Cancer Immunology, Inc. · Mar 18, 2026
Publication

Amniotic Fluid Derived Extracellular Vesicles And Uses Thereof For Wound Healing

EP3930734A1 · Merakris Therapeutics, LLC · Mar 18, 2026
Publication

Water Soluble Cannabis Composition

EP4003328A1 · Etain IP, LLC · Mar 18, 2026
Publication

Liquid Dressing Compositions Comprising Shellac And Metals For Veterinary Uses

EP4009988A1 · Cambridge Enterprise Limited · Mar 18, 2026
Publication

Liquid Dressing Compositions Comprising Shellac And Metals

EP4009987A1 · Cambridge Enterprise Limited · Mar 18, 2026
Publication

Method For Treating Cough By Using Diaminopyrimidine Compound

EP3960179A1 · Beijing Tide Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Compound For Treating Autoimmune Skin Diseases Caused By Inflammation, And Use Thereof

EP3964212A1 · Generos Biopharma Ltd. · Mar 18, 2026
Publication

Compositions And Methods For The Treatment Of Retinal Degeneration

EP3962545A1 · Lineage Cell Therapeutics, Inc. · Mar 18, 2026
Publication

Method For Treating Endometriosis Associated Pain By Using Diaminopyrimidine Compound

EP3960178A1 · Beijing Tide Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Cosmetic Formulation, Process For Its Production And Method Of Use Of The Same As Cosmetic Hair Treatment Alternative To Silicones

EP3930853A1 · Pettenon Cosmetics S.p.A. Società Benefit · Mar 18, 2026
Publication

Oral Care Composition

EP3930667A1 · UNILEVER GLOBAL IP LIMITED · Mar 18, 2026
Publication

Pyrazolylbenzene 1,3 Diols For Diseases Associated With G Protein Coupled Receptor 18 And In Combination With Transient Receptor Potential Vanilloid 1

EP3901142A1 · Consejo Superior de Investigaciones Científicas (CSIC) · Mar 18, 2026
Publication

Supercritical Carbon Dioxide Based Methodology To Formulate Bioactive Preparations

EP3895695A1 · Universidad Autónoma de Madrid · Mar 18, 2026
Publication

Topical Aqueous Pharmaceutical Compositions Of Flurbiprofen And Chlorhexidine

EP3834815A1 · Sanovel Ilac Sanayi ve Ticaret A.S. · Mar 18, 2026
Publication

A Composition For The Delivery Of Biologically Active Agents And Uses Thereof

EP3946458A1 · Cytomatrix Limited · Mar 18, 2026
Publication

Nicotine Pouch

EP4031107A1 · Enorama Pharma AB · Mar 18, 2026
Publication

Trehalose Rich Yeast Extract

EP3976808A1 · Ohly GmbH · Mar 18, 2026
Publication

Compositions And Methods For The Treatment Of Tauopathy

EP3963083A1 · Voyager Therapeutics, Inc. · Mar 18, 2026
Publication

Methods For Treatment Of Subjects With Preexisting Immunity To Viral Transfer Vectors

EP3962537A1 · Cartesian Therapeutics, Inc. · Mar 18, 2026
Publication

Peptides And Combinations Of Peptides For Use In Immunotherapy Against An Infection By Sars Cov 2 (Covid 19)

EP3892297A1 · Eberhard Karls Universität Tübingen Medizinische Fakultät · Mar 18, 2026
Publication

Sustained Release Dosage Forms For A Jak1 Inhibitor

EP3721873A1 · Incyte Holdings Corporation · Mar 18, 2026
Publication

Beta Glucan For Use In The Treatmane Of A Remission

EP3858362A1 · Pleuran, s.r.o. · Mar 18, 2026
Publication

Composition Comprising Non Viable Probiotic Bacteria And Its Use In Therapy

EP3682890A1 · Proge Farm S.r.l. · Mar 18, 2026
Publication

Oligonucleotides For Modulating Atxn2 Expression

EP3947677A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Composition Comprising A Combination Of A Protoporphyrin Ix (Ppix) Precursor Selected From Methyl Aminolevulinate (Mal) And Aminolevulinic Acid(ala), Ethylenediaminetetraacetic Acid (Edta) And Epigallocatechin Galate (Egcg) For Topical Use In Photodynamic Therapy

EP3970714A1 · Universidad De La Frontera · Mar 18, 2026
Publication

Substituted Indoles And Methods Of Use Thereof

EP3837240A1 · Epizyme, Inc. · Mar 18, 2026
Publication

Multi Specific Binding Proteins That Bind Bcma, Nkg2 D And Cd16, And Methods Of Use

EP3833392A1 · Dragonfly Therapeutics, Inc. · Mar 18, 2026
Publication

Glycine Based Peptides For Use In The Treatment Of Non Alcoholic Fatty Liver Disease And Non Alcoholic Steatohepatitis

EP3833373A1 · Diapin Therapeutics LLC · Mar 18, 2026
Publication

Cellulose Based Topical Formulations

EP3833362A1 · YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD · Mar 18, 2026
Publication

Aerosol Generation

EP3905902A1 · Nicoventures Trading Limited · Mar 18, 2026
Publication

Pre Filled Syringe And Pre Filled Syringe Production Method

EP3831429A1 · Zeon Corporation · Mar 18, 2026
Publication

Lipid Prodrugs Of Pregnane Neurosteroids And Uses Thereof

EP3829590A1 · Seaport Therapeutics, Inc. · Mar 18, 2026
Publication

Dual Agonist Fusion Proteins

EP3829622A1 · Duke University · Mar 18, 2026
Publication

Sustained Release Compositions Comprising A Therapeutic Agent For Treating Depression Or Anxiety And Uses Thereof

EP3829539A1 · Taiwan Liposome Company, Ltd. · Mar 18, 2026
Publication

Kif18 A Inhibitors

EP3897852A1 · Amgen Inc. · Mar 18, 2026
Publication

Novel P62 Ligand Compound, And Composition For Preventing, Alleviating, Or Treating Proteinopathies Comprising Same

EP3828163A1 · Autotac Inc. · Mar 18, 2026
Publication

Zinc Arginine Halide Complex

EP3897864A1 · Colgate-Palmolive Company · Mar 18, 2026
Publication

Straightening Process For Keratin Fibers

EP3893834A1 · L'OREAL · Mar 18, 2026
Publication

Methods Of Treating Schizophrenia And Other Neuropsychiatric Disorders

EP3894556A1 · University of Rochester · Mar 18, 2026
Publication

Ready To Use Diclofenac Stick Packs

EP3893865A1 · APR APPLIED PHARMA RESEARCH S.A. · Mar 18, 2026
Publication

Tricyclic Crbn Ligands And Uses Thereof

EP3817748A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Novel Hyaluronic Acid Hydrolyzing Enzyme Mutant And Pharmaceutical Composition Comprising Same

EP3636752A1 · Alteogen Inc. · Mar 18, 2026
Publication

C11 Cyclic Substituted 13 Membered Macrolides And Uses Thereof

EP3883945A1 · Zikani Therapeutics, Inc. · Mar 18, 2026
Publication

Novel Ketogenic Compounds, Compositions, Methods And Use Thereof

EP3806906A1 · 9500-0535 Québec Inc. · Mar 18, 2026
Publication

Cannabinoid Composition And Methods Of Treatment Using The Same

EP3806845A1 · Cannpal Animal Therapeutics Limited · Mar 18, 2026
Publication

Methods For Expansion Of Natural Killer (Nk) Cell Subset And Related Compositions And Methods

EP3884041A2 · Indapta Therapeutics, Inc. · Mar 18, 2026
Publication

Liquid Formulation Containing Botulinum Toxin And Stabilizing Agent, And Preparation Method Therefor

EP3782605A1 · Hugel Inc. · Mar 18, 2026
Publication

Prodrugs Of Hiv Reverse Transcriptase Inhibitors

EP3785714A1 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Lyophilization Container

EP3769618A1 · Terumo BCT, Inc. · Mar 18, 2026
Publication

Stable Pharmaceutical Composition And Methods Of Using Same

EP3797591A1 · Amarin Pharmaceuticals Ireland Limited · Mar 18, 2026
Publication

Use Of One Or A Combination Of Phytocannabinoids In The Treatment Of Epilepsy

EP3718603A1 · Jazz Pharmaceuticals Operations UK Limited · Mar 18, 2026
Publication

Antibodies Directed Against Staphylococcus Aureus Leukotoxins

EP3864040A1 · Medimmune, LLC · Mar 18, 2026
Publication

High Affinity Monoclonal Antibodies (Mabs) Against Cell Surface Expressed Human Carbonic Anhydrase Ix (Hca Ix), And Uses Thereof

EP3784700A1 · National Research Council of Canada · Mar 18, 2026
Publication

Mycobacterial Antigen Compositions And Methods Of Use

EP3784275A2 · Children's National Medical Center · Mar 18, 2026
Publication

Cell Sheet For Transplantation Into A Living Body And Method For Producing Same

EP3786280A1 · Sapporo Medical University · Mar 18, 2026
Publication

Sustained Release Composite Particles, Method For Producing Sustained Release Composite Particles, Dry Powder, And Wallpaper

EP3786231A1 · Toppan Printing Co., Ltd. · Mar 18, 2026
Publication

Use Of An Amino Acid Derivative Of Glucosamine For The Topical Non Therapeutic Treatment Of Skin Aging

EP3853238A1 · Cartilago S.r.l. · Mar 18, 2026
Publication

Identification Of Granins As The Pathogenic Factor Of Alzheimer's Disease And Compositions And Methods For Inhibiting Granin Aggregation And Treating Alzheimer's Disease

EP3773547A1 · Yoo, Seung Hyun · Mar 18, 2026
Publication

Multifunctional Nanoparticles For Theragnosis

EP3799886A1 · Universidad de Granada · Mar 18, 2026
Publication

Compositions For Providing A Protective Barrier

EP3856129A1 · L'OREAL · Mar 18, 2026
Publication

Aqueous Oral Care Solutions, Methods, Kits, And Tooth Surfaces Having A Coating Derived From The Oral Care Solution

EP3843692A1 · Solventum Intellectual Properties Company · Mar 18, 2026
Publication

Anti Human Lag 3 Monoclonal Antibody And Use Thereof

EP3778632A1 · Jiangsu Huaiyu Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Methods And Compositions For Blocking Interaction Between Non Glycosylated Pd 1 Polypeptides

EP3773916A1 · TrueBinding, Inc. · Mar 18, 2026
Publication

Camptothecin Peptide Conjugates

EP3773736A1 · Seagen Inc. · Mar 18, 2026
Publication

Recombinant Protein Targeting Pd L1 And Vegf

EP3891182A1 · ImmuneOnco Biopharmaceuticals (Shanghai) Inc. · Mar 18, 2026
Publication

Dpep 1 Binding Agents And Methods Of Use

EP3887390A1 · Arch Biopartners, Inc. · Mar 18, 2026
Publication

Irak Degraders And Uses Thereof

EP3886904A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Anti Pd L1/Anti 4 1 Bb Bispecific Antibodies And Uses Thereof

EP3891187A1 · ABL Bio Inc. · Mar 18, 2026
Publication

Compounds, Compositions, And Methods For Modulating Ferroptosis And Treating Excitotoxic Disorders

EP3887351A1 · The Trustees of Columbia University in the City of New York · Mar 18, 2026
Publication

Thiamine Compound, Preparation Method And Pharmaceutical Composition Thereof

EP3889160A1 · Shanghai Raising Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Methods And Compositions For Treating Or Preventing The Development Of Food Allergies

EP3876966A1 · The Children's Medical Center Corporation · Mar 18, 2026
Publication

Method Of Determining Responsiveness To Cell Therapy In Dilated Cardiomyopathy

EP3877764A1 · University of Miami · Mar 18, 2026
Publication

Formulations Of Antiviral Compounds

EP3870183A1 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Proto Antigen Presenting Synthetic Surfaces, Activated T Cells, And Uses Thereof

EP3867353A1 · Berkeley Lights, Inc. · Mar 18, 2026
Publication

Ultrasound Induced Exosomes Obtained From Human Dermal Fibroblasts, For Use In Wound Healing

EP3862009A1 · STEMON Inc. · Mar 18, 2026
Publication

A Method For Treating An Auditory Neuropathy Spectrum Disorder

EP3856227A1 · Akouos, Inc. · Mar 18, 2026
Publication

Neoantigen Compositions; And Methods Of Preparation And Use Thereof

EP3856909A1 · Thomas Jefferson University · Mar 18, 2026
Publication

Supar And Prediction And Treatment Of Acute Kidney Injury

EP3856244A1 · Reiser, Jochen · Mar 18, 2026
Publication

Suppressing Ige Mediated Allergy By Desensitization With Monovalent Anti Fc Epsilon Ri Alpha Monoclonal Antibody

EP3852804A1 · University of Cincinnati · Mar 18, 2026
Publication

Generation Of Pancreatic Progenitor Cells And Beta Cells From Human Pluripotent Stem Cells

EP3841199A1 · The Penn State Research Foundation · Mar 18, 2026
Publication

Methods And Compositions Comprising Surfactant Protein D (Sp D)

EP3774875A1 · Airway Therapeutics, Inc. · Mar 18, 2026
Publication

A Uv Filter Based On Polyhydroxybutyrate And A Method Of Its Preparation

EP3560479A1 · NAFIGATE Corporation, a.s. · Mar 18, 2026
Publication

Nanoparticle Compositions

EP3572072A1 · Anterios, Inc. · Mar 18, 2026
Publication

Long Lasting Effect Of New Botulinum Toxin Formulations

EP3845241A1 · Medy-Tox, Inc. · Mar 18, 2026
Publication

Tolerogenic Synthetic Nanocarriers For Antigen Specific Deletion Of T Effector Cells

EP3871691A1 · Cartesian Therapeutics, Inc. · Mar 18, 2026
Publication

Combinations Of Relacorilant And A Radiolabelled Somatostatin Analogue For Use In Localising Neuroendocrine Tumours

EP3897629A1 · Corcept Therapeutics Incorporated · Mar 18, 2026
Publication

Fusion Protein Constructs For Complement Associated Disease

EP3893916A2 · Akebia Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions For Stabilizing Bacteria And Uses Thereof

EP3890505A1 · Seres Therapeutics, Inc. · Mar 18, 2026
Publication

Antimicrobial Compositions Comprising Modified Clay And Nonionic Triblock Copolymers

EP3897530A1 · Unilever IP Holdings B.V. · Mar 18, 2026
Publication

Vsv Chimeric Vectors

EP3884043A1 · Vira Therapeutics GmbH · Mar 18, 2026
Publication

Stabilized Chemical Composition

EP3790385A1 · Syngenta Crop Protection AG · Mar 18, 2026
Publication

Lactobacillus Paracasei Strain And Use Thereof

EP3792342A1 · Kobiolabs, Inc. · Mar 18, 2026
Publication

Method

EP3874031A1 · Oxford University Innovation Limited · Mar 18, 2026
Publication

Gel State Composition And Production Method Therefor

EP3738576A1 · KANEKA CORPORATION · Mar 18, 2026
Publication

Completely Humanized Monoclonal Neutralizing Antibody For Tetanus Toxin And Application Thereof

EP3733699A1 · Zhuhai Trinomab Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Continuous Administration Of Vitamin B12 For The Treatment Of Cerebrovascular Disease Or Central Nerve Injury

EP3730144A1 · Osaka University · Mar 18, 2026
Publication

Interaction Of Fibroblasts And Immune Cells For Activation And Uses Thereof

EP3716988A1 · Figene, LLC · Mar 18, 2026
Publication

Method For Producing Cell Mass Including Pituitary Tissue, And Cell Mass Thereof

EP3715450A1 · Sumitomo Chemical Company, Limited · Mar 18, 2026
Publication

Dicycloplatin For Use In Treating And/Or Preventing Pain

EP3714881A1 · Medoncare Pharmaceutical Co., Ltd · Mar 18, 2026
Publication

Protein Degraders And Uses Thereof

EP3684365A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Hepatitis B Antiviral Agents

EP3675637A1 · Enanta Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Novel Method For Producing Antibody Drug Conjugate

EP3677568A1 · Daiichi Sankyo Company, Limited · Mar 18, 2026
Publication

Biomimetic Nanomaterials And Uses Thereof

EP3661563A1 · The Ohio State Innovation Foundation · Mar 18, 2026
Publication

Oxidized Polysaccharides And Methods Of Use Thereof

EP3821880A1 · President and Fellows of Harvard College · Mar 18, 2026
Publication

Dynamic Clusters Of Atom Particles Activated In Extracellular Fluid

EP3934626A1 · Xichuan Seawagen Company Limited · Mar 18, 2026
Publication

Compounds Including A Mutant Kras Sequence And A Lipid And Uses Thereof

EP3758713A1 · Elicio Therapeutics, Inc. · Mar 18, 2026
Publication

N Cyano 7 Azanorbornane Derivatives And Uses Thereof

EP3837262A1 · Amgen Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Mitochondrial Neurogastrointestinal Encephalopathy

EP3755351A1 · Entrada Therapeutics, Inc. · Mar 18, 2026
Publication

Group B Adenovirus Containing Formulation

EP3746128A1 · Akamis Bio Limited · Mar 18, 2026
Publication

Combination Therapy For Treatment Of Leukemia

EP3740215A1 · City St George's, University of London · Mar 18, 2026
Publication

Ophthalmic Composition

EP3827818A1 · Zaklady Farmaceutyczne Polpharma S.A. · Mar 18, 2026
Publication

Molecules For Use To Treat Or Prevent Cardiac Diseases

EP3835316A1 · Universiteit Gent · Mar 18, 2026
Publication

Drug Device Configured For Wireless Communication

EP3643355A1 · Pop Test Abuse Deterrent Technology LLC · Mar 18, 2026
Publication

Compounds And Methods For Treating An Epileptic Disorder

EP3636264A1 · The Regents of the University of California · Mar 18, 2026
Publication

Diagnosis Of Blistering Autoimmune Diseases

EP3644060A1 · EUROIMMUN Medizinische Labordiagnostika AG · Mar 18, 2026
Publication

Compositions And Methods For Inducing Conformational Changes In Cereblon And Other E3 Ubiquitin Ligases

EP3827836A1 · Celgene Corporation · Mar 18, 2026
Publication

An Anhydrous Composition For Nail Polishes And A Method Of Treating Nails With The Polish Composition

EP3819008A1 · Chromavis S.p.A. · Mar 18, 2026
Publication

Inhibition Of Autism Spectrum Disorder Using Ribosomal Read Through Compounds

EP3684346A1 · Friedrich Miescher Institute for Biomedical Research · Mar 18, 2026
Publication

Heterocyclic Compound

EP3661931A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Composition For Removing Noise From Mri And Pad Using Same

EP3593823A1 · Baek, Jung-Eun · Mar 18, 2026
Publication

Dihydrobenzimidazolones

EP3679027A1 · C4 Therapeutics, Inc. · Mar 18, 2026
Publication

Salts And Solid State Forms Of Plinabulin

EP3661927A1 · Assia Chemical Industries Ltd. · Mar 18, 2026
Publication

Doramapimod For Use In The Treatment Of Endotoxemia

EP3582781A1 · The University of Melbourne · Mar 18, 2026
Publication

Production Of Recombinant Vaccine Against Helminths In Pichia Pastoris

EP3572514A1 · Tendler, Miriam · Mar 18, 2026
Publication

Enzymatic Replacement Therapy And Antisense Therapy For Pompe Disease

EP3638788A1 · Erasmus University Medical Center Rotterdam · Mar 18, 2026
Publication

Probenecid For Use In Treating Epileptic Diseases, Disorders Or Conditions

EP3651758A1 · Paris Sciences et Lettres · Mar 18, 2026
Publication

Devices For The Treatment Of Body Surface Disorders

EP3638356A1 · Verrica Pharmaceuticals Inc. · Mar 18, 2026
Publication

Methods Of Treating Brain Tumors Using Combination Therapy

EP3638245A1 · Les Laboratoires Servier · Mar 18, 2026
Publication

Scored Tablet

EP3630071A1 · Ceva Santé Animale · Mar 18, 2026
Publication

Hydroxynorketamine For The Use In The Treatment Of Depression

EP3641742A2 · Ketabon GmbH · Mar 18, 2026
Publication

A Process For The Preparation Of Polymorphic Form Of Robenacoxib

EP3830072A1 · KRKA, d.d., Novo mesto · Mar 18, 2026
Publication

Nitrogenated Heterocyclic Amide Compound, And Use Thereof For Medical Purposes

EP3747888A1 · Japan Tobacco Inc. · Mar 18, 2026
Publication

Lactobacillus Plantarum For Skin Care

EP3813859A1 · Symrise AG · Mar 18, 2026
Publication

Protein Degraders And Uses Thereof

EP3737666A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Crbn Ligands And Uses Thereof

EP3737675A1 · Kymera Therapeutics, Inc. · Mar 18, 2026
Publication

Ophthalmic Composition Comprising Inorganic Copper Salt For The Treatment Of Myopic Progression

EP3735209A1 · University of Utah Research Foundation · Mar 18, 2026
Publication

Moisturizing Cream And Lotion

EP3793508A1 · Kenvue Brands LLC · Mar 18, 2026
Publication

Oxadiazoles As Agonists Of The Muscarinic M1 And/Or M4 Receptor

EP3810607A1 · Nxera Pharma UK Limited · Mar 18, 2026
Publication

Oral Care Compositions Comprising Fluoride Ions

EP3793507A1 · The Procter & Gamble Company · Mar 18, 2026
Publication

Use Of ß Glucan Extract In Immunopotentiation Of An Avian Animal

EP3787677A1 · Lesaffre et Compagnie · Mar 18, 2026
Publication

Methods For Isolating Tumor Specific Immune Cells From A Subject For Adoptive Cell Therapy And Cancer Vaccines

EP3624774A1 · Crititech, Inc. · Mar 18, 2026
Publication

Virus Vectors For Targeting Ophthalmic Tissues

EP3773743A1 · Ginkgo Bioworks, Inc. · Mar 18, 2026
Publication

Pharmaceutical Compositions For Prevention And/Or Treatment Of Infections

EP3784223A1 · European Molecular Biology Laboratory · Mar 18, 2026
Publication

Her2 Targeting Molecules Comprising De Immunized, Shiga Toxin A Subunit Scaffolds

EP3573652A1 · Molecular Templates, Inc. · Mar 18, 2026
Publication

Tick Vaccine

EP3781198A1 · Technische Universität Braunschweig · Mar 18, 2026
Publication

Modulators Of Cystic Fibrosis Transmembrane Conductance Regulator, Pharmaceutical Compositions, Methods Of Treatment, And Process For Making The Modulator

EP3774825A1 · Vertex Pharmaceuticals Incorporated · Mar 18, 2026
Publication

Engineered Cytolytic Immunecell

EP3775895A1 · Autolus Limited · Mar 18, 2026
Publication

The Use Of Sgc Activators And Sgc Stimulators For The Treatment Of Cognitive Impairment

EP3787610A1 · Bayer Aktiengesellschaft · Mar 18, 2026
Publication

Sirnas With At Least Two Ligands At Different Ends

EP3775209A1 · Silence Therapeutics GmbH · Mar 18, 2026
Publication

Compositions For Prolonging The Survival After Orthopic And Heteropic Xenogeneic Heart, Kidney, Lung Or Liver Transplantations

EP3773570A2 · Reichart, Bruno · Mar 18, 2026
Publication

Anti Cd25 For Tumour Specific Cell Depletion

EP3765510A1 · Tusk Therapeutics Ltd · Mar 18, 2026
Publication

Compounds For The Treatment Of Kinase Dependent Disorders

EP3743417A1 · Exelixis, Inc. · Mar 18, 2026
Publication

Attenuation System And Use Thereof

EP3795684A1 · CAS Lamvac (Guangzhou) Biomedical Technology Co., Ltd. · Mar 18, 2026
Publication

Acute And Chronic Mitochondrial Electron Transport Chain Dysfunction Treatments And Graphenic Materials For Use Thereof

EP3615077A1 · William Marsh Rice University · Mar 18, 2026
Publication

Antisense Targeting Dynamin 2 And Use For The Treatment Of Centronuclear Myopathies And Neuropathies

EP3610016A1 · Genethon · Mar 18, 2026
Publication

Multi Arm Polymer Conjugates Of Tlr Agonist Compounds And Related Immunotherapeutic Treatment Methods

EP3568162A1 · Nektar Therapeutics · Mar 18, 2026
Publication

Antibodies Recognizing Genetic Variants

EP3579873A1 · Roche Diagnostics GmbH · Mar 18, 2026
Publication

Composition For The Treatment Of Gastrointestinal Disorders

EP3570877A1 · Neilos S.r.l. · Mar 18, 2026
Publication

Bionconjugates Of Polysaccharides And Elastin Like Polypeptides And Uses Thereof

EP3628333A1 · Institut Polytechnique de Bordeaux · Mar 18, 2026
Publication

Method Of Directed Differentiation Producing Corneal Endothelial Cells, Compositions Thereof, And Uses Thereof

EP3517604A1 · Astellas Institute for Regenerative Medicine · Mar 18, 2026
Publication

Organic Compositions To Treat Beta Enac Related Diseases

EP3431604A1 · Arrowhead Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Messenger Rna Comprising Functional Rna Elements

EP3773745A1 · ModernaTX, Inc. · Mar 18, 2026
Publication

Methods For Improving The Microbiome And Its Systemic Effect Involving Administration Of Carotenoids, Specifically Lycopene

EP3784061A1 · IP Science Limited · Mar 18, 2026
Publication

Anti Cd40 Antibodies For Use In Prevention Of Graft Rejection

EP3774913A1 · Novartis AG · Mar 18, 2026
Publication

Compositions And Methods For Cleansing Keratin Fibers

EP3787591A1 · L'OREAL · Mar 18, 2026
Publication

C5 Ar Inhibitors For Use In The Treatment Of Chemotherapy Induced Iatrogenic Pain

EP3723744A2 · Dompé farmaceutici S.p.A. · Mar 18, 2026
Publication

Core Shell Microcapsule With A Polyamine Based Thermosetting Shell

EP3728545A1 · Givaudan SA · Mar 18, 2026
Publication

Uses And Methods For Il 2 Superagonists, Agonists, And Fusions Thereof

EP3641814A1 · Medicenna Therapeutics Inc. · Mar 18, 2026
Publication

Dosage Regimen Of Vidofludimus For Use In The Treatment Of Chronic Inflammatory And/Or Autoimmune Diseases

EP3713554A1 · Immunic AG · Mar 18, 2026
Publication

Energizing Food Supplement And Use Thereof

EP3700358A1 · Isella, Glauco · Mar 18, 2026
Publication

Anti Cldn 5 Antibody, And Drug Containing Said Antibody

EP3623384A1 · Osaka University · Mar 18, 2026
Publication

Lipophenolic Compounds For Use In The Treatment Of Viral Infections Disease And Central Nervous System Disorders.

EP3706732A1 · Université de Montpellier · Mar 18, 2026
Publication

Igf 1 R Monoclonal Antibodies And Uses Thereof

EP3638320A2 · Centre for Probe Development and Commercialization · Mar 18, 2026
Publication

Pharmaceutical Composition Comprising Attenuated Streptococcus Pneumoniae Strains And Use Thereof

EP3616715A1 · Ildong Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Hepatitis C Virus Gene Sequences And Methods Of Use Therefor

EP3618859A1 · Vanderbilt University · Mar 18, 2026
Publication

Recombinant Egfl7, Egfl7 Antibodies, And Uses Thereof

EP3615075A1 · Ohio State Innovation Foundation · Mar 18, 2026
Publication

New Treatment Of Sma

EP3691647A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Combination Therapies With Ehmt2 Inhibitors

EP3612181A1 · Epizyme, Inc. · Mar 18, 2026
Publication

Anti Pd L1 Antibody And Use Thereof

EP3612565A1 · R-Pharm Overseas, Inc. · Mar 18, 2026
Publication

Compositions And Methods For Treating Pain Disorders

EP3610019A2 · Mansell, John · Mar 18, 2026
Publication

Compositions And Methods For Treating Transthyretin (Ttr) Mediated Amyloidosis

EP3684931A1 · Alnylam Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Nucleic Acid Molecule For Reduction Of Papd5 And Papd7 M Rna For Treating Hepatitis B Infection

EP3645723A1 · F. Hoffmann-La Roche AG · Mar 18, 2026
Publication

Mutant Alpha 1 Antitrypsin Compositions And Use Thereof

EP3606951A1 · B.G. Negev Technologies and Applications Ltd., at Ben-Gurion University · Mar 18, 2026
Publication

Biologic For The Treatment Of Cancer

EP3606548A2 · Loma Linda University · Mar 18, 2026
Publication

Extract Of Vegetation Waters For Use In Treating Damage To The Cardiovascular System

EP3684392A1 · Fattoria La Vialla Di Gianni, Antonio E Bandino Lo Franco - Societa' Agricola Semplice · Mar 18, 2026
Publication

Allele Specific Silencing Therapy For Dynamin 2 Related Diseases

EP3548619A1 · Association Institut de Myologie · Mar 18, 2026
Publication

Compositions For The Treatment Of Disease

EP3448987A2 · Voyager Therapeutics, Inc. · Mar 18, 2026
Publication

Compositions For The Treatment Of Disease

EP3448875A1 · Voyager Therapeutics, Inc. · Mar 18, 2026
Publication

Therapeutically Triggering An Innate Immune Response In A Target Tissue

EP3448397A1 · Qu Biologics Inc. · Mar 18, 2026
Publication

Method Of Treating Or Preventing Liver Conditions

EP3445450A1 · CSL Limited · Mar 18, 2026
Publication

Anti Human Vista Antibodies And Use Thereof

EP3442579A2 · Immunext, Inc. · Mar 18, 2026
Publication

High Affinity B7 H6 Antibodies And Antibody Fragments

EP3442576A1 · Trustees of Dartmouth College · Mar 18, 2026
Publication

Methods Of Treatment Using Chlorotoxin Conjugates

EP3442996A2 · Blaze Bioscience, Inc. · Mar 18, 2026
Publication

Plectin 1 Binding Antibodies And Uses Thereof

EP3439692A2 · ZIELBIO, INC. · Mar 18, 2026
Publication

Compositions And Methods Related To Polycytotoxic T Cells

EP3439688A1 · The Regents of the University of California · Mar 18, 2026
Publication

Chimeric Antigen Receptors Targeting Cancer

EP3436070A2 · University of Southern California · Mar 18, 2026
Publication

Neuroactive Steroids, Compositions, And Uses Thereof

EP3426257A1 · Sage Therapeutics, Inc. · Mar 18, 2026
Publication

Microglia Derived From Pluripotent Stem Cells And Methods Of Making And Using The Same

EP3423564A1 · New York Stem Cell Foundation, Inc. · Mar 18, 2026
Publication

Chelated Psma Inhibitors

EP3497108A1 · Cancer Targeted Technology LLC · Mar 18, 2026
Publication

Anti Il1 Rap Antibodies And Antibody Drug Conjugates

EP3638697A1 · Bluefin Biomedicine, Inc. · Mar 18, 2026
Publication

Treatment Of Cutaneous Disorders

EP3634370A1 · Verrica Pharmaceuticals Inc. · Mar 18, 2026
Publication

Modulators Of The Integrated Stress Pathway

EP3704115A1 · Calico Life Sciences LLC · Mar 18, 2026
Publication

Agent For Preventing Or Treating Brain Atrophy

EP3632431A1 · FUJIFILM Toyama Chemical Co., Ltd. · Mar 18, 2026
Publication

Methods Of Treating High Risk Multiple Myeloma

EP3703749A1 · Janssen Biotech, Inc. · Mar 18, 2026
Publication

Kit For Preparing A Body Treatment Product

EP3723716A1 · Henkel AG & Co. KGaA · Mar 18, 2026
Publication

Pharmaceutical Forms Of Diazabicyclooctane Derivatives And Manufacturing Method Thereof

EP3687993A1 · Meiji Seika Pharma Co., Ltd. · Mar 18, 2026
Publication

C Terminal Cdnf And Manf Fragments, Pharmaceutical Compositions Comprising Same And Uses Thereof

EP3619227A1 · MyNeuroCure Oy · Mar 18, 2026
Publication

Anti Cgrp/Anti Il 23 Bispecific Antibodies And Uses Thereof

EP3618862A1 · Eli Lilly and Company · Mar 18, 2026
Publication

Calcium Peroxide Nanoparticles As Adjuvant Therapy

EP3618874A2 · University Of Ulster · Mar 18, 2026
Publication

Multispecific Molecules And Uses Thereof

EP3612563A1 · Marengo Therapeutics, Inc. · Mar 18, 2026
Publication

System For Forming A Cosmetic Composition And Skin Care Management System

EP3606653A1 · L'OREAL · Mar 18, 2026
Publication

Pectin Microcapsules, Method For The Manufacture And Use Thereof

EP3609477A1 · Université de Bourgogne · Mar 18, 2026
Publication

Amhrii Binding Compounds For Preventing Or Treating Lung Cancers

EP3609919A1 · Exelixis, Inc. · Mar 18, 2026
Publication

(+) Alpha Dihydrotetrabenazine For Use In The Treatment A Movement Disorder

EP3606529A1 · Adeptio Pharmaceuticals Limited · Mar 18, 2026
Publication

Small Molecule Dcn1 Inhibitors And Therapeutic Methods Using The Same

EP3601245A1 · The Regents of The University of Michigan · Mar 18, 2026
Publication

Antibodies For The Treatment Of Erbb 2/Erbb 3 Positive Tumors

EP3600411A1 · Merus B.V. · Mar 18, 2026
Publication

Bi Specific Aptamer

EP3416690A1 · City of Hope · Mar 18, 2026
Publication

Donepezil Transdermal Delivery System

EP3490558A1 · Corium, LLC · Mar 18, 2026
Publication

A Fusion Peptide Comprising Glp 2 And Elastin Like Peptides

EP3412300A1 · Duke University · Mar 18, 2026
Publication

Dry Powder Formulations And Methods For Treating Pulmonary Diseases

EP3184099A1 · Pulmatrix Operating Company, Inc. · Mar 18, 2026
Publication

A Freeze Dried Parenteral Composition Of Tigecycline And Process For Preparation Thereof

EP3302494A1 · Gufic Biosciences Limited · Mar 18, 2026
Publication

Non Peptidic Gapdh Aggregation Inhibitor

EP3305762A1 · Osaka Prefecture University Public Corporation · Mar 18, 2026
Publication

Method For Connecting Two Objects Using A Polymer Composition, And A System For Use In A Cosmetic Procedure

EP3370809A1 · TSK Laboratory Europe B.V. · Mar 18, 2026
Publication

Use As An Odor Neutralizer For Ammonia And Primary Or Secondary Amines

EP3377031A1 · Firmenich SA · Mar 18, 2026
Publication

Use Of Oligosaccharide Compositions To Enhance Weight Gain

EP3288389A1 · Children's Hospital Medical Center · Mar 18, 2026
Publication

Platelet Like Proteo Microparticles And Method Of Using Such In Drug Delivery

EP3285742A1 · Academia Sinica · Mar 18, 2026
Publication

Antisense Oligonucleotides For Use In Treating Alzheimer's Disease

EP3362562A1 · Academisch Ziekenhuis Leiden, also acting under the name Leiden University Medical Centre (LUMC) · Mar 18, 2026
Publication

Therapeutic Una Oligomers And Uses Thereof

EP3277289A1 · Arcturus Therapeutics, Inc. · Mar 18, 2026
Publication

Pharmaceutical Composition Comprising Valsartan And Sacubitril For Use In The Treatment Of A Disorder Or Disease In A Specific Patient Group

EP3355880A1 · Novartis AG · Mar 18, 2026
Publication

Nicotine For Use In Reducing Frequency Of Falls In Subjects With Parkinson's Disease

EP3727043A1 · Golden Gait Biotech, S.L. · Mar 18, 2026
Publication

Method And Composition For Preventing And Treating Viral Infections

EP3675813A1 · Global Biolife Inc. · Mar 18, 2026
Publication

Poziotinib Against Cancer Cells Bearing Egfr Or Her2 Exon 20 Mutations

EP3541832A1 · Board of Regents, The University of Texas System · Mar 18, 2026
Publication

2,4 Dspbn For Use In A Method Of Treatment Of Cochlear Synaptopathy Or Vestibular Synaptopathy By Enhancing Synaptogenesis And Neuritogenesis

EP3532042A1 · Hough Ear Institute · Mar 18, 2026
Publication

Compounds And Uses Thereof

EP3529245A1 · Janssen Pharmaceutica NV · Mar 18, 2026
Publication

Magnesium Picolinate Compositions And Methods Of Use

EP3525770A1 · Bonafide Health, LLC · Mar 18, 2026
Publication

Heterodimeric Immunoglobulin Constructs And Preparation Methods Thereof

EP3504234A1 · Beijing Hanmi Pharmaceutical Co., Ltd. · Mar 18, 2026
Publication

Blood Brain Barrier Permeable Heteroduplex Nucleic Acid

EP3517610A1 · National University Corporation Tokyo Medical and Dental University · Mar 18, 2026
Publication

Cyclic Compound

EP3511320A1 · Takeda Pharmaceutical Company Limited · Mar 18, 2026
Publication

Inhibitors Of Cytochrome P450 Family 7 Subfamily B Member 1 (Cyp7 B1) For Use In Treating Diseases

EP3558304A2 · Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) · Mar 18, 2026
Publication

Ebola Virus Antibodies And Binding Agents Derived Therefrom

EP3487521A2 · Emory University · Mar 18, 2026
Publication

Process For Preparing Biodegradable Polymers Of High Molecular Weight

EP3565852A1 · Pharmathen S.A. · Mar 18, 2026
Publication

Compositions Comprising Low Impact Ampakines For Treating Attention Deficit Disorders

EP3436021A1 · RespireRx Pharmaceuticals, Inc. · Mar 18, 2026
Publication

A Combination Of Two Or More Anti C5 Antibodies And Methods Of Use

EP3247723A1 · Chugai Seiyaku Kabushiki Kaisha · Mar 18, 2026
Publication

Food And/Or Nutraceutical Composition Containing Palmitoylethanolamide (Pea)

EP3130336A1 · Graal S.r.l. · Mar 18, 2026
Publication

Commercially Viable Synthesis Of Cantharidin And Bioactive Cantharidin Derivatives

EP3233865A2 · Verrica Pharmaceuticals Inc. · Mar 18, 2026
Publication

Methods And Compositions Particularly For Treatment Of Attention Deficit Disorder

EP3212172A1 · Purdue Pharma · Mar 18, 2026
Publication

Modified Antimir 138 Oligonucleotides

EP3177722A1 · Agency for Science, Technology and Research · Mar 18, 2026
Publication

Microemulsions And Uses Thereof

EP3151664A1 · Archer Daniels Midland Company · Mar 18, 2026
Publication

Polynucleotide Agents Targeting Complement Component C5 And Methods Of Use Thereof

EP3191591A1 · Alnylam Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Biosynthetic Production Of Acyl Amino Acids

EP3145482A1 · Evonik Operations GmbH · Mar 18, 2026
Publication

New Method For Producing Outer Membrane Vesicles

EP3129462A1 · INSERM - Institut National de la Santé et de la Recherche Médicale · Mar 18, 2026
Publication

Protein Aqueous Suspension

EP3064213A1 · Terumo Kabushiki Kaisha · Mar 18, 2026
Publication

Gene Therapy For The Regeneration Of Chondrocytes Or Cartilage Type Cells

EP3043825A1 · FibroBiologics, Inc. · Mar 18, 2026
Publication

7 A Heterocycle Substituted 6, 6 Difluoro Bicyclic Himbacine Derivatives

EP3035930A1 · Merck Sharp & Dohme LLC · Mar 18, 2026
Publication

Anti Zika Virus Antibodies And Methods Of Use

EP3484917A1 · Regeneron Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Bacteria Based Gel Compositions For Topical Applications And Uses Thereof

EP3463291A1 · Probiotical S.p.A. · Mar 18, 2026
Publication

Polynucleotides Encoding Citrin For The Treatment Of Citrullinemia Type 2

EP3458081A1 · ModernaTX, Inc. · Mar 18, 2026
Publication

Fc Receptor Mediated Drug Delivery

EP3436066A1 · Checkmate Pharmaceuticals, Inc. · Mar 18, 2026
Publication

Crystalline Forms Of N [2 (3 Hydroxy 3 Methylbutyl) 6 (2 Hydroxypropan 2 Yl) 2 H Indazol 5 Yl] 6 (Trifluoromethyl)pyridine 2 Carboxamide

EP3448847A1 · Bayer Pharma Aktiengesellschaft · Mar 18, 2026
Publication

Solid State Forms Of Venetoclax And Processes For Preparation Of Venetoclax

EP3426655A1 · Assia Chemical Industries Ltd. · Mar 18, 2026
Publication

A Method Of Manufacturing A Suspension Of Nanoparticles Of Tadalafil Or Sildenafil Citrate

EP3576741A1 · Dukebox SP. Z O.O. · Mar 18, 2026
Publication

Unit Structure Type Pharmaceutical Composition For Nucleic Acid Delivery

EP2842546A1 · The University of Tokyo · Mar 18, 2026
Publication

Optimised Subcutaneous Therapeutic Agents

EP2838566A2 · Cantab Biopharmaceuticals Patents Limited · Mar 18, 2026
Publication

Bispecific Antibodies Against Her2 And Cd3

EP2699262A2 · Genmab A/S · Mar 18, 2026
Publication

Antiviral And Retroviral Composition, In Particular For Treating Aids

EP2456452A1 · Commin, Alix Roland · Mar 18, 2026